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ABSTRACT
The vascular structure of mammalian skeletal muscle has been intensively
investigated for the last seventy years. Since the early work of Pappenheimer and
Barlow, the existence of a parallel dual vascular pathway has been suggested to
explain the differences between total flow and clearance rates of a variety of infused
substances. Direct microscopy studies using superficial muscles have shown that the
microvascular arterioles have very frequent connections with the capillary modules of
the associated co nnective tissue and adipose tissue within skeletal muscle. In more
recent times, Clark and colleagues have identified two vascular pathways according
to the opposing actions of two groups of vasoconstricting agents. While all increase
perfusion pressure, Type A vasoconstrictors (low dose noradrenaline (NAd),
vasopressin, angiotensin II) increase oxygen uptake but Type B vasoconstrictors
(serotonin, high dose noradrenaline) decrease hindlimb oxygen consumption. The
opposing effects on oxygen consumption are thought to arise from selective
vasoconstriction of the microvasculature. Type A vasoconstrictors redirect blood into
muscle tissue capillary beds (termed nutritive bed) whilst Type B vasoconstrictors
redirect blood into the associated connective tissue, adipose and septum capillary
beds (termed non-nutritive bed). Many of the previous studies are based on
variations of an in situ rat, isolated perfused hindlimb model, having low vascular
tone and often with insufficient oxygen carrying capacity to support active
metabolism. In vivo, skeletal intramuscular blood redistribution during exercise
occurs principally via the release of vasodilatory metabolites and the nervous system.
This thesis used a novel in vivo model to test the hypothesis that nutritive and non nutritive blood flow distribution can still be observed under conditions of high vascular
tone and oxygen delivery at rest and in metabolically active (contracting) muscle.
Utilising the high vascular tone, it also tests the hypothesis that the vascular
pathways can be differentiated using vasodilators.

Male Wistar rats were anaesthetised with sodium pentobarbital (6mg ⋅ 100g -1
i.p.). The right femoral artery was cannulated to supply blood to the left femoral artery
(perfused) at a constant flow (basal 1 ml ⋅ min -1 , contraction 2 ml ⋅ min -1 ) via a pump.
Perfused hindlimb pressure was recorded distal to the pump and passive venous
return occurred from the left femoral vein to the right external jugular vein. Systemic
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blood pressure was recorded from the left common carotid artery. Polyethylene
cannulae were filled with heparinized 0.9% saline containing 6% w/v dextran70. The
left sciatic nerve was isolated and stimulated (5Hz) to produce twitch contraction in
the lower hindlimb muscle bundle and developed tension was recorded. Vasoactive
drugs (2 constrictor, 8 dilator) were prepared with saline and 0.01% ascorbic acid,
and injected into the arterial loop. Blood was sampled from the venous and arterial
loops and oxyg en consumption determined using the Fick equation.
In the autoperfused rat hindlimb, the Type B vasoconstrictor increased
perfusion pressure and caused a significant decrease in basal hindlimb oxygen
consumption, however during muscle contraction this effect on oxygen consumption
was diminished. The Type A vasoconstrictor had no significant effect on hindlimb
oxygen consumption during significant increases in perfusion pressure. Eight
vasodilators with a variety of mechanisms of action were screened at rest but none
were observed to decreases hindlimb oxygen consumption in a fashion similar to
Type B vasoconstrictors. Increases in oxygen availability at rest via increased
nutritive flow by noradrenaline and vasodilator infusion had no effect upon basal
metabolic rate. Therefore, during adequate oxygen delivery, increased availability
has no effect upon metabolic demand. Isoprenaline and histamine significantly
increased hindlimb oxygen consumption during the contraction protocol, whilst there
was no significant effect observed at rest. It can be concluded that selective
vasoconstriction occurs in vivo, however during muscle contraction, local release of
vasodilatory metabolites can overcome exogenous vasoconstriction. These results
confirm the possible existence of a dual vascular pathway however blood flow
redistribution via vasodilation is likely determined by the locale of vasodilator release
rather than differences in receptor distribution.
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CHAPTER ONE

Literature Review

1

1.1

DUAL CIRCULATION IN SKELETAL MUSCLE

1.1.1 Introduction
The relationship between skeletal muscle metabolism and the distribution of
blood throughout its vascular network has been a major focus of researchers for
some time now. Since the work of Pappenheimer in the 1940’s, controversy has
surrounded the existence of dual circulation in skeletal muscle. A lack of histological
evidence for classical shunts such as large arterio -venous anastomoses (Barlow et
al. 1958; Piiper and Rosell 1961) has tended to contradict physiological evidence
supporting dual circulation. Redistribution of blood flow brought about by an increase
in vascular resistance is thought to play an oxygen-saving role. However, this will not
protect from oxygen consumption by the tissue at the peripheral level. Oxygen
uptake is determined by tissue partial pressure of oxygen (Po 2), capillary Po2, or by
intercapillary distance (Proctor et al. 1981). It is subsequently thought that the
existence of dual circulation, with one route having a low metabolic demand, could
play a crucial role (Stainsby and Lambert 1979). It has been postulated that
preferential tissue blood flow results from heterogeneity of perfusion, which occurs at
the capillary level of the vascular network. Studies have shown that skeletal muscle
blood flow shunting does not require specific anatomical structure (Hyman et al.
1959; Cieslicki and Przybyski 2000) such as anastomoses found in the lungs (Frazier
et al. 2000; Do et al. 2001) and the digit (Burch and DePasquale 1962). Blood flow
distribution within skeletal muscle has been defined as a tightly regulated process
involving stimulation by tissue metabolites, integrated with the vascular mechanisms
of neural, flow-dependent and myogenic responses (Rivers and Frame 1999).

1.1.2 Evidence For Dual Circulation
Evidence has been presented supporting dual circulation from studies where
total blood flow into the muscle did not correlate with metabolic or heat transfer
responses. These studies have termed the rou tes nutritive and non-nutritive.
Pappenheimer (1941) studied neurohormonal effects on oxygen consumption in the
perfused hindlimb and isolated dog gastrocnemius. Oxygen consumption decreased
during stimulation of the sympathetic vasoconstrictor nerve whilst vasodilation, via
adrenaline (α- and β-adrenoceptor agonist) infusion, led to an increase in oxygen
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consumption. Pappenheimer reported an increase in arterial-venous temperature
difference during reduced perfusion pressure or adrenaline infusion and a decrease
during vasoconstrictor nerve stimulation. These changes could not be accounted for
by changes in metabolism. It was hypothesised that during vasoconstrictor nerve
stimulation, blood flow is diverted into areas of the muscle where oxygen
consumption and surfaces for heat loss are reduced.
Othe r experimental evidence has come from studies using clearance rates of
various substances, including radioactive sodium (24Na) (Walder 1953, 1955; Barlow
et al. 1959, 1961), potassium (42K) (Barlow et al. 1961), rubidium (86Rb) (Renkin and
Rosell 1962), xenon (133Xe) (Sejrsen and Tönnesen 1968), iodine (131I) (Rapaport et
al. 1952; Hyman et al. 1959; Ballard et al. 1964), antipyrine (Renkin 1971), inert
gases (Piiper et al. 1985), and hydrogen (Nakamura et al. 1972; Harrison et al.
1990), before and during infusion of adrenaline. Renkin (1955) described the
vascular bed of perfused cat hindlimb as having well perfused and poorly perfused
areas which are not identifiable with any particular compartmental tissue of the
hindlimb, and which have differing responses to vasoactive agents such as
adrenaline. The clearance rates of radioactive substances did not correlate with total
blood flow within the perfused hindlimbs. The discrepancies between the infused
substance washout and venous outflow could be explained by a dual vascular
pathway, with a considerable fraction of total flow passing through the non -nutritive
route (Piiper et al. 1985).
Increases in skeletal muscle blood flow during adrenaline infusion do not
match with the clearance of arterially infused

24

Na in various whole animal and

isolated muscle models (Barlow et al. 1959, 1961). In these studies there was a
strong correlation between

24

Na clearance and total blood flow during sympathetic

vasoconstrictor nerve stimulation. There was no change in

24

Na clearance rates

during cholinergic vasodilator nerve stimulation. It was suggested at the time that the
vasodilator nerve acted on intramuscular shunts (non -nutritive route) to redistribute
this flow (Hyman et al. 1959). Barlow et al. (1959, 1961) described the clearance of
24

Na from skeletal muscle during adrenaline infusion as having two areas: fast and

slow clearance areas. If the removal by the lymphatic system is considered
negligible, then the rate of clearance of

24

Na is dependent upon the number of

capillaries perfused and/or surface area (Miller and Wilson 1951). Autoradiographs
showed that periods of slow clearance was representative of the clearance of

24

Na

from the intramuscular septa and tendon, whereas the rapid clearance wa s attributed
to the deposition amongst the muscle fibres. It was concluded that skeletal muscle
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has two circulations, one being concerned with the delivery of nutrients to the muscle
fibres (nutritive), and the other delivering nutrients to the intramuscular septa and
tendons (non-nutritive). Further these circulations are affected differently by
adrenaline (Barlow et al. 1959, 1961). It should be noted that the exchange in each
compartment may be either flow limited or diffusion limited, depending on the
perfused compartment and the substance under consideration (Renkin 1971).
In a following study, Renkin and Rosell (1962) showed that vascular
resistance increased during sympathetic adrenergic stimulation, while both 86Rb and
oxygen clearance decreased. This decrease in clearance was thought to occur
through vasoconstriction of perfused nutritive capillaries resulting in redistribution of
blood flow into the non -nutritive capillaries.
Isotopic xenon clearance from the perfused cat gastrocnemius was found to
have deviations from a monoexponential curve, which was thought to be due to
either uneven binding or uneven perfusion of the tissue (Kjellmer et al. 1967; Sejrsen
and Tönnesen 1968). Sejrsen and Tönnesen (1968) concluded that there are no
fixed in-parallel compartments within the muscle and that countercurrent exchange of
133

Xe across the vessel wall explains the shape of the clearance curve.

133

Xe had a

uniform distribution within the skeletal muscle during rest. However, it has been
reported that

133

Xe has a ten times preferential binding affinity to adipose tissue

compared to muscle tissue although the fat content of cat muscle is very low (1%)
(Kjellmer et al. 1967).
Further evidence of dual circulation came from Harrison et al. (1990), who
concluded that there was local redistribution of capillary flow after stimulation of the
rabbit sciatic nerve to contract the vastus medialis. At low frequencies (< 2Hz) there
was an increase in capillary flow without an increase in arterial flow whilst a clear
redistribution of flow was observed. There was no correlation between capillary flow
and femoral arterial flow, and nor between oxygen consumption and femoral arterial
flow during hydrogen clearance from the perfused rabbit hindlimb at rest. Harrison et
al proposed a model for oxygen-dependent regulation of capillary blood flow involving
two compartments, one with high-flow and the other with normal-flow.

1.1.1.1 Direct Observation Studies
Further supporting evidence for the existence of a non-nutritive pathway was
obtained through the use of direct intravital microscopy techniques in a variety of
animals (rabbit (Branemark and Eriksson 1972; Borgström et al. 1988), and rat
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(Grant and Payling Wright 1970)). One of the first studies to describe the perfusion of
the non -nutritive vessels following vasoactive agonist infusion was conducted by
Grant and Payling Wright (1970). They observed the vasculature in the tibial tendon
of the rat biceps femoris muscle and infused a variety of vasoactive agents.
Acetylcholine and histamine dilated arterio-venous (non -nutritive) vessels in the
tendon whilst noradrenaline and adrenaline both vasoconstricted the same vessels.

Figure 1.1: Taken from Clark et al. (2000). Schematic illustration of vasculature in the tenuissimus muscle of
rabbits. Transverse arteriole supplies both capillaries in the muscle tissue and the adjacent tissue.

A large body of supporting evidence has come from the use of the
tenuissimus muscle of the rabbit, due to the accessibility and transparency of the
muscle, which allows it to be viewed under a microscope. The tenuissimus muscle
originates at the sacral bone, runs down the crural fascia and inserts into the
coccygeal bone (Branemark and Eriksson 1972; Eriksson and Myrhage 1972). This
muscle is supplied by vasculature comprised of a transverse arteriole that supplies
both the muscle fibres and associated connective tissue (Figure 1.1). An increase in
oxygen availability by elevated ambient oxygen levels reduces blood flow to the
muscle with no concomitant change in flow to the connective tissue. A decrease in
oxygen availability led to similar changes in both muscle and connective tissue flow.
This was attributed to proportionate resistance regulation in the transverse and
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terminal arteriole in view of the lack of evidence for precapillary sphincters (Lindbom
and Arfors 1984).
Borgström et al. (1988) indicated that blood flow could be controlled between
the two vascular routes (nutritive and non-nutritive) by vasoactive agents. Their study
used isoprenaline (β-adrenoceptor agonist), adrenaline and adrenaline with
propranolol (β-adrenoceptor antagonist). During isoprenaline infusion there was a
fractional redistribution of flow from the muscle tissue to the adjacent connective
tissue (nutritive to non -nutritive) via dilation of the transverse arteriole, as well as a
slight constriction of the terminal arteriole. Adrenaline infusion induced constriction of
both the transverse and terminal arterioles, with a minimal blockage of this
constriction during propranolol infusion. Adrenaline over the dose range decreased
total flow to the muscle and connective tissue without affecting the proportion of
distribution between either tissue. They concluded that β-adrenergic control of
skeletal blood flow is via distribution between the transverse arteriole (connective
tissue) and the terminal arteriole (muscle).
Borgström et al. (1990) also observed microvascular regulation in rabbit
skeletal muscle after a 30% haemorrhage. During the 30 minute post-haemorrhage
period, the transverse arteriole gradually constricted to 75% of the control diameter.
The terminal arteriole constricted to 65% within 10 minutes and then gradually
returned to 80% of the prehaemorrhage diameter. During the early posthaemorrhage phase , the reduced total flow was diverted into the connective tissue
(non-nutritive) at the expense of nutritive flow to the muscle tissue to retain nutrient
levels for the vital organs such as the brain and heart. This flow redistribution was
gradually reversed to restore nutritive flow to the muscle tissue. It has been shown
that during times of hypovolaemia, this expansion of intravascular volume is primarily
mediated through β2 -adrenoceptor activity (Lundvall and Hillman 1978; Hillman et al.
1982).
The capillary network is arranged into fundamental units termed modules
(Figure 1.2). The number of capillaries per module is dependent upon age and other
factors (Berg and Sarelius 1995). These modules have interconnections with
transverse arterioles and venules but lack connections with other modules (Skalak
and Schmid-Schönbein 1986). Berg et al. (1997) observed that discrete stimulation of
a small bundle of muscle fibres produced an increase in erythrocyte flux and velocity
only in the capillary module supplying the contracting muscle fibres and not the
feeding arteriole (Gorczynski et al. 1978; Berg et al. 1997). No change was seen in
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the erythrocyte flux in the other capillary module arising from the same terminal
arteriole. Furthermore, dilation was observed in the associated transverse arteriole
but not in other transverse arterioles belonging to other unstimulated modules from
the same network. This study and other similar studies have identified a mechanism
connecting increases in skeletal muscle metabolism during contraction to local
capillary recruitment via the terminal arteriole control of capillary modules (Delashaw
and Duling 1988; Berg et al. 1997). There are multiple signalling pathways by which
conducted vasodilation can be initiated in microvessels underlying contracting
muscle fibres (discussed below) (Cohen et al. 2000). The spread of a vasodilatory
signal which is initiated by muscle contraction at the arteriolar level seems likely to
have the capacity to aid in the coordination of muscle metabolism and blood flow
during exercise (Murrant and Sarelius 2000b).

Figure 1.2: Adapted from Berg et al. (1997). Simplified schematic diagram (not to scale) showing the
relationships between the distal ramifications of the arteriolar microvasculature. Feed arteries give rise to transverse
arterioles and these give rise to terminal arterioles. Downstream of each terminal arteriole lie a capillary network
which consists of a number of distinct capillary module or units.

Although the majority of direct observation studies have been performed in
the tenuissimus muscle (a non weight bearing muscle) the outcomes can be
extrapolated to the regulation of larger muscles. The vascular arrangements of the
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tenuissimus, the thicker biceps femoris, lateral and medial heads of the
gastrocnemius and the soleus of the cat have very similar patterns. The tenuissimus
muscle has a vascular arrangement like that of a singular basic unit of a thicker
muscle (Myrhage and Eriksson 1980). Lund et al. (1987) determined that capillaries
are arranged into units or modules fed by a single arteriole and largely drained by a
single venule in the tibialis anterior muscle.

1.1.1.2 Pharmacological Studies
The majority of physiological evidence for a dual circulation has arisen from
pharmacological studies in various animal models (Table 1.1). The relationship
between blood flow and twitch development has been demonstrated by a number of
studies (Sonnenchein and Hirvonen 1961; Hirvonen and Sonnenschein 1962;
Hirvonen et al. 1964; Peoples 2004). These studies have concluded that contractile
force is reduced in a dose -dependent manner during vasodilator infusion into the
constant flow hindlimb (Hirvonen et al. 1964). It is possible that this depression could
be overcome by a specific antagonist of the vasodilator, or by an increase in blood
flow rate, although there was no evidence of neuromuscular blockade. Hirvonen and
Sonnenschein (1962) concluded that a redistribution of blood flow within the muscle
and associated connective tissue could account for these results. Generally these
studies did not report any metabolic measures such oxygen consumption or lactate
efflux.
Acetylcholine is thought to be released locally from vascular endothelium in
response to n
i creased shear stress within the arterioles resulting in vasodilation
(Brock et al. 1998). At rest, acetylcholine increases regional blood volume and mean
hydrostatic capillary pressure, resulting in net fluid movement from the blood into the
tissue (Kjellmer and Odelram 1965). It is thought that this effect is consequent upon
the greater dilatation of precapillary arterioles than postcapillary venules (Ablad and
Mellander 1963; Mellander 1966). Nutritive flow at rest is increased by acetylcholine
through vasodilation resulting in increased heterogeneity (Vetterlein et al. 1977). In
contracting muscle, acetylcholine decreases nutritive or increases non -nutritive flow
in the perfused cat gastrocnemius-soleus muscles. Acetylcholine delays sodium
iodide (NaI) washout, and has been shown to either increase total flow without a
change in force or decrease force without a change in total flow (Sonnenchein and
Hirvonen 1961; Hirvonen et al. 1964).
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Table 1.1: Adapted from Altura (1971). Summary table of the vascular actions of humoral and chemical
substance that have implications in the regulation of skeletal muscle blood flow.

Humoral (blood-borne) substance
Agent
Response
Catecholamines:

Chemical (locally produced-metabolic)
Agent
Response
Adenosine and
VD
Adenine nucleotides

Adrenaline
Noradrenaline
Dopamine

VD, VC

Hypoxaemia

VD

VC

H+

VD

VD, VC

K+

VD

Inorganic Phosphate

VD

Amines:
Serotonin

VC, VD

Hypercapnea

VD

Histamine

VD

Kreb’s Cycle

VD

Intermediates
Acetylcholine

VD

Polypeptides:

G-I Tract polypeptides:
Glucagon

VD

Angiotensin

VC

Cholecystokinin

VD

Kinins

VD

Secretin

VD

Vasopressin

VC

Insulin

Oxytocin

VC, VD

Prosta glandins
Hyperosmolarity

VC, VD
VD

VD: Vasodilation; VC: Vasoconstriction.

The focus on skeletal muscle flow distribution has been revived in recent
years through the interest in dual circulation and its potential role in muscle
metabolism (Clark et al. 1995). The constant flow perfused rat hindlimb has been the
main method used by Clark and co-workers investigating haemodynamic effects on
skeletal muscle metabolism. Vasoactive agents can regulate skeletal muscle
metabolism and contribute to whole body thermogenesis through regulation of the
microvasculature (Clark et al. 1994; Clark et al. 1995). One of the first studies by this
group showed that physiological doses of vasopressin (V1-receptor agonist) and
angiotensin II (AT 1-receptor agonist) can increase oxygen uptake by up to 70% of
basal uptake (Colquhoun et al. 1988). In Colquhoun et al. (1988) studies there was
no effect on vasopressin and angiotensin II induced increase in oxygen uptake during
α- and β-adrenoceptor blockade by the infusion of phentolamine and propranolol
respectively. Angiotensin II administration increases tetanic force development but
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not twitch force development in the perfused rat hindlimb (Rattigan et al. 1996). The
vasodilators, nifedipine (Ca 2+ channel blocker), nitroprusside (cyclic GMP and nitric
oxide donor) and isoprenaline infused together blocked the effect of vasopressin and
angiotensin II on oxygen uptake and perfusion pressure (Colquhoun et al. 1988;
Colquhoun et al. 1990) while nitroprusside alone was shown not to inhibit either
oxygen uptake or force development during hindlimb stimulation in the same
preparation (Ye et al. 1990).

The effects of various vasoconstricting agents on perfusion pressure and
oxygen uptake in the constant flow non -recirculating perfused rat hindlimb show
differing results (Table 1.2). While all increase perfusion pressure, some increase
oxygen consumption whilst others reduce it. Clark et al have grouped
vasoconstrictors that increase perfusion pressure in the hindlimb into two categories
depending on their effects on metabolic activity (Clark et al. 1994; Clark et al. 1995).
Type A vasoconstrictors increase oxygen uptake whilst type B vasoconstrictors
decrease oxygen uptake. Those Type A vasoconstrictors studied have shown
changes consistent with an increase in muscle metabolism (Table 1.3). The effect of
the vasoactive agents on oxygen uptake could be due to: a) receptor location on the
resistance arterioles, which redirect the perfusate into previously under-perfused
regions of the hindlimb; b) receptor location is not only on the vasculature but also on
the skeletal muscle to directly increase oxygen uptake; or c) oxygen uptake by the
vascular smooth muscle to maintain vasoconstriction (Côté et al. 1985).
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Table 1.2: Adapted from Clark et al. (1995) Vasoconstrictor stimuli that increase (Type A) or decrease (Type B)
oxygen uptake in perfused rat hindlimb.

Agonist
Type A
Noradrenaline
Adrenaline
Phenylephrine
Methoxamine
Amidephrine
Ephedrine
Norephedrine
Angiotensin II
Vasopressin
Capsaicin
Dihydrocapsaicin
[6]-Gingerol
[6]-Shogaol
Low frequency sympathetic nerve
stimulation (0.5-4Hz)

Change From Control at Maximum Dose
of Agonist %
Perfusion Pressure
Oxygen Uptake
52, 130
67
160
167
24
70
57
133
121
54.5
49
30
30
6

46, 52, 77
25, 67
50, 57
25
28
10
18
64
66
22
18
21
21
6

700, 200, 380
76
110

-22.7, -15, -10
-30.3
-35

›

œ

96
37

-21.2
-16

Type B
Noradrenaline (≥ 1µM)
Serotonin
Capsaicin (> 1µM)
Dihydrocapsaicin (> 1µM)
[6]-Gingerol (≥ 20µM)
High-frequency sympathetic nerve
stimulation (> 4Hz)

Hindlimbs were perfused at 25o C with constant flow. › and œ, indicative of an increase or decrease,
respectively, when compared with control (vehicle only) perfusion.

Two vasoactive agents that have been the primary focus of the Clark group
are noradrenaline (Type A) and serotonin (Type B) due to their opposing effects on
the perfused hindlimb oxygen consumption despite similar effects on perfusion
pressure (Table 1.3). Noradrenaline is both a neurotransmitter and a mitogenic
hormone (Buu et al. 1993) which acts on both α 1- and α 2-adrenoceptors (Gardiner
and Peters 1982). Decreases in capillary surface area associated with increasing
doses of noradrenaline and serotonin infusion are reflected in a progressive
decrease in both capillary diffusion capacity and capillary filtration capacity. These
changes are associated with increases in both pre- and post-capillary resistance,
which cause an increase in both arterial and capillary resistance via vasoconstriction
(Rippe and Folkow 1980). During local applicatio n of noradrenaline, a temporary
reduction of capillary flow occurs via arteriolar constriction (Dietrich and Tyml 1992b).
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Table 1.3: Adapted from Clark et al (1994). Vasomodulator effects on perfused hindlim b.
Parameter:
Perfusion pressure

Vasoconstrictors
Type A
Type B
h
h

Oxygen uptake

h

i

Lactate efflux

h

i

Fatty Acid efflux

h

i

Glycerol efflux

h

i

Urate efflux

h

i

Insulin mediated glucose uptake

Not Tested

i

Skeletal muscle contraction

Not Tested

i

Perfusate distribution volume

h

i

Vascular space using fluorescein-labelled dextran

h

i

Corrosion cast volume

h

i

Erythrocyte flux from previously perfused areas

h

i

1-MX metabolism

h

i

Effect of the following on vasoconstriction
and associated changes:
Removal of external Ca2 +
Replacement of O2 with N2
Addition of N 3-, CNAddition of vasodilator

Blocked
Blocked
Blocked
Blocked1

Not Blocked
Not Blocked
Not Blocked
Blocked2

Hindlimbs were perfused at 25o C with constant flow. 1. Includes nitroprusside, nifedipine, isoprenaline,
adenosine, AMP, ADP, ATP and UTP. 2. Includes nitroprusside, carbamyl choline and isoprenaline (partial
blockade).

While noradrenaline normally increases both perfusion pressure and oxygen
uptake, it has been observed to decrease hindlimb oxygen uptake at supraphysiological levels (> 1µM) (Dora et al. 1992). Increases in perfusion pressure occur
through constriction of both pre- and postcapillary vessels (Haddy et al. 1957;
Hudlicka 1973) which result in a temporary reduction of flow in the perfused capillary
(Dietrich and Tyml 1992b). During hypoxia or the infusion of sodium cyanide or azide
(both uncouple mitochondrial oxidative phosphorylation), noradrenaline-induced
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vasoconstriction is almost totally abolished (Dora et al. 1992) and the effect on
perfusion pressure and oxygen uptake is also inhibited by the combined infusion of
nifedipine, nitroprusside and isoprenaline (Colquhoun et al. 1990). It has been
speculated that at lower doses, noradrenaline-induced vasoconstriction is dependent
upon oxidative metabolism, whilst during higher doses it is dependent on anaerobic
metabolism (Dora et al. 1992).
Serotonin is found in the central nervous system and platelets, and is a potent
skeletal muscle vasoconstrictor (Rang et al. 1995). Serotonin does not significantly
change total resistance in the perfused dog hindlimb. However, serotonin does
increase large artery and vein resistance (5-HT 2A mediated) and decreases small
vessel resistance (5-HT 1 mediated) (Haddy et al. 1957). The response to locally
infused serotonin is dependent upon the initial level of vascular resistance (Dietrich
and Tyml 1992b). Serotonin decreases muscle vascular resistance when initial
resistance is high and increases resistance if initial resistance is low (Cheng and
Shibata 1980). This variable response occurs when the initial resistance is
manipulated neurogenically or via metabolically induced vasodilation (Emerson et al.
1973). Maximal serotonin induced vasodilation occurs during sympathetic stimulation
in vivo, which may be caused by inhibiting the release of noradrenaline (Haddy et al.
1959; McCubbin et al. 1962; Emerson et al. 1973; Blackshear et al. 1985).
Alternatively, serotonin at high concentrations has a direct vasodilator effect in vitro
that can only be observed when the initial resistance is high or selectively blocked by
ketanserin (5-HT 2 –antagonist) (McLennan and Taylor 1984). Serotonin has been
shown to decrease oxygen uptake and lactate production in rat skeletal muscle which
is blocked via ketanserin (Dora et al. 1991). During hypoxia or the infusion of cyanide
or azide there is no effect on serotonin-induced vasoconstriction or decreased
oxygen uptake. It has been speculated that serotonin vasoconstriction is capable of
anaerobic metabolism through the use of exogenous glucose when glycogen stores
are exhausted (Dora et al. 1992). Aerobic contractility is inhibited during serotonin
infusion which is thought to occur through selective vasoconstriction resulting in
diminished nutrient delivery through redirection of blood flow. In the study conducted
by Dora et al, the vasoconstrictor action of serotonin was not over come by local
vasoactive metabolites released during skeletal muscle contraction of the perfused
rat hindlimb (Dora et al. 1994). Serotonin has also been shown to inhibit insulinmediated glucose uptake, especially in muscles that are rich in fast-twitch glycolytic
fibres and reduce free fatty acid uptake across the hindlimb by selective
vasoconstriction (Rattigan et al. 1993; Baron and Clark 1997; Clerk et al. 2003).
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Using three different experimental protocols, Newman et al. (1996) studied
the differing effects of low dose noradrenaline (Type A) and serotonin (Type B) on
the vascular routes in the rat hindlimb. One method evaluated the release of
entrapped erythrocytes from previously equilibrated hindlimbs into a perfusate
medium that did not contain erythrocytes. Low dose noradrenaline markedly
increased the erythrocyte efflux levels whilst serotonin showed no change in
erythrocyte washout.
The vascular entrapment of fluorescein-labelled dextran showed that low
dose noradrenaline recruits a new vascular space (most likely nutritive vessels)
without closing off any pre -existing perfused areas. Access to the new space could
be re -accessed only with a second infusion of low dose noradrenaline. In contrast,
serotonin was found to close off previously perfused areas, (most likely nutritive
vessels) and did not recruit any new regions, this effect being reversible only by the
removal of serotonin (Newman et al. 1996).
Corrosion of vascular casts of the rat hindlimb vasculature using 12µm
microspheres resulted in low dose noradrenaline significantly increasing the filling of
smaller vessels but had no effect on the volume of the arterial tre e compared to the
basal castings. Serotonin and high dose noradrenaline (> 1µM) decreased the total
extent of arterial vascular filling and cast weight (Newman et al. 1996).
The metabolic changes induced during either noradrenaline or serotonin
infusion can be reversed by the infusion of microspheres (< 15µm). It was proposed
that during microsphere infusion, the route receiving most flow would be blocked first,
and thus flow will be redirected to the more constricted route. The end result in
studies by Vincent et al showed that while perfusion pressure further increases, the
metabolic effect of the vasoconstrictor is reversed (Vincent et al. 2001a; Vincent et al.
2001b). However, as the distribution patterns of the microspheres could not
differentiate between noradrenaline and serotonin vasoconstriction sites, it was
concluded that the nutritive and non-nutritive routes are distributed evenly throughout
the muscle (Vincent et al. 2001b).
Clark et al has attempted to use the endothelial cell metabolism of 1methyxanthine as a marker of capillary flow (Rattigan et al. 1997a). 1-Methyxanthine
(1-MX) is converted solely to 1-methylurate (1-MU) via xanthine oxidase (XO), which
is a capillary endothelial derived enzyme. The recoveries of 1-MX and 1-MU are
quantitative and 1-MX has no effect on vascular resistance in perfused rat hindlimb
studies. The conversion of 1-MX to 1-MU is inhibited by allopurinol (an XO -specific
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inhibitor) and xanthine. The rationale for this is that if Type A and B vasoconstrictors
act by altering the pattern of perfusate flow within muscle there would be an
associated change in the exposure of exogenous substrate to enzymes located in the
vasculature (Clark et al. 1997). Changes in 1 -MX metabolism were found to positively
correlate with changes in nutritive flow in perfused rat hindlimb muscle. The lowest
production of 1-MU was found during serotonin induced vasoconstriction, and the
highest during muscle contraction (Clark et al. 2000). Serotonin had no effect on the
distribution of 15µm fluorescent microspheres and was concluded that 1-MX
metabolism is a potential marker for the decrease in muscle nutritive flow or nutrient
access during serotonin vasoconstriction.
Activation of the sympathetic nervous system increases perfusion pressure
through vasoconstriction (Hall et al. 1997). The sympathetic nervous system also has
a biphasic effect on oxygen consumption (Table 1.2) which together with the
vasoconstrictor effect is though to act via the α 1-adrenoceptor (discussed below).
The va scular network in the septa (connective tissue such as perimysium,
endomysium and epimysium) and tendon could serve as a functional shunt for the
skeletal muscle blood supply (Barlow et al. 1959, 1961; Grant and Payling Wright
1970; Newman et al. 1997; Clark et al. 2000). Vasoactive agents known to regulate
oxygen uptake in the constant flow perfused hindlimb were also found to regulate
blood flow in the associated connective tissue. An inverse relationship between
tendon vessel blood flow and oxygen uptake suggests that the amount of perfusion in
the tendon and surrounding connective tissue plays a major regulatory role of total
hindlimb metabolism by acting as a functional shunt to reciprocally control nutritive
flow (Newman et al. 1997).
Therefore, noradrenaline and serotonin may act at different sites in the
vasculature to distribute blood to different areas in the hindlimb supporting the earlier
hypothesis of Barlow and his colleagues. It has been suggested that Type A and B
vasoconstrictors act at different sites in the hindlimb vasculature (Figure 1.3) to
influence muscle metabolism by either increasing or decreasing nutrien t access to
muscle by controlling different capillary flow routes (Newman et al. 1996). It is
suggested that: a) T ype A vasoconstrictors increase nutritive flow (that is provide an
increase in oxygen to highly metabolic tissues) by constricting points on the
transverse arteriole distal to the muscle but proximal to the connective tissue; and b)
Type B vasoconstrictors increase non-nutritive flow by constricting at branch points
leading from the transverse arteriole such as the terminal arterioles supplying the
muscle cells thereby directing blood flow away from the muscle.
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Figure 1.3: Taken from (Clarket al. (1995). A simplified representation of the mechanism of dual circulation
control by vasoconstrictors.

1.1.1.3 Measurement of Nutritive and Non-Nutritive Flow Distribution
As evidence arose to support the existence of dual circulation in skeletal
muscle, the question was raised as to the distribution of blood flow between the two
routes. Friedman (1966) first estimated that 75% of total flow was non-nutritive in an
isolated constant flow perfused dog hindlimb that was denervated and resting.
Radioactive albumin was used to measure total blood volume and 86Rb to measure
non-nutritional volume. It was assumed that the ability of

86

Rb to diffuse into the

tissue was a result of passing through well-perfused channels and being limited at
the capillary wall.

86

Rb has an extraction simila r to potassium, where there is

complete capillary extraction in the nutritive pathway with no extraction occurring
during times of high non -nutritive flow (Friedman 1965, 1968, 1971). Therefore the
extraction of

86

Rb by skeletal muscle has an inverse relationship to total blood flow

(Renkin and Rosell 1962; Friedman 1969).
Using direct observation of the rabbit tenuissimus muscle it was estimated
that around 33% of the flow entering the transverse arteriole from the central artery
was distributed into the connective tissue at rest (Lindbom and Arfors 1984).
Because the tenuissimus muscle mass is not evenly distributed, but rather
concentrated in the middle and decreases towards the edge, it was re-estimated that
the connective tissue flow fraction was closer to 20-25% of total flow. In a similar
study measuring skeletal muscle capillary haematocrit, it was calculated that 20% of
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transverse arterial blood flow passes through the non -nutritive route (associated
connective tissue) of the rabbit tenuissimus muscle (Ley et al. 1988). Connective
tissue microcirculation represents a significant functional erythrocyte shunt under
normal resting condition and has a haematocrit discharge 30% greater than systemic
haematocrit (Ley et al. 1988) due to structural factors (see structure of skeletal
muscle vasculature).
Clearance rates of iodine from the skinned leg of the anaesthetised cat during
hyperaemia following arterial occlusion were higher than pre-occlusion levels. It was
suggested that redistribution of blood flow from non-nutritive into the nutritive route
could explain this increase in clearance following occlusion (Ballard et al. 1964).
From the difference between pre-occlusion and post-occlusion clearance rates it was
calculated that at rest 40% of total muscle blood flow passes through the nonnutritive route.
Using clearance of hydrogen ions, Harrison et al. (1990) reported two areas
of clearance similar to earlier studies. One area contained high flow capillaries where
mean flow is six-times higher than the normal flow capillaries in the other area. Using
Poiseuille’s law (flow = 4 th power of the radius), Harrison et al calculated that if just
13% (high flow) of all capillaries within the skeletal muscle had a diameter of 7.5µm
(Potter and Groom 1983) then theses capillaries could carry 71% of total blood flow.
Therefore if the remaining 87% (normal flow) had a mean diameter of 5.5µm (Potter
and Groom 1983) then these would carry the remaining 29% resulting in a 4:21 ratio
of nutritive to non-nutritive flow.
However, a major obstacle in measuring non-nutritive flow has been the lack
of knowledge of specific characteristics of the non-nutritive vessels that would assist
in devising an accurate method. The endothelial cell metabolism of 1-methyxanthine
(1-MX) has been utilised as a marker of nutritive capillary flow (Clark et al. 1997;
Rattigan et al. 1997a). The changes in 1-MX metabolism were found to positively
correlate with changes in nutritive flow in perfused muscle.
Table 1.4 shows the summary of the calculated distribution of flow from a
variety of models. The majority of these studies concluded that there is substantial
non-nutritive flow in skeletal muscle during resting conditions.
It has been postulated that non -nutritive capillary beds could act as a flow
reserve and amplify nutrient delivery during exercise (Clark et al. 1998a). If the ratio
of nutritive to non-nutritive flow is 4:21 as suggested by Harrison et al. (1990),
exercise could result in a six fold increase alone through red istribution from non-
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nutritive to nutritive vessels. Also a three-fold increase in cardiac output would result
in an overall eighteen fold increase in nutritive flow during exercise (Clark et al.
1998a). Similarly, post-exercise blood flow would remain elevated for a considerable
time, where the balance between nutritive and non-nutritive flow may be important in
allowing muscle to recover through removal of lactate and restoring nutrient supplies
to energy stores (Clark et al. 1998b).

Table 1.4: Summary table of the distribution of flow through the skeletal muscle vasculature at rest.
Model

Method

Nutritive Flow

Non-Nutritive
Flow

Isolated perfused
dog hindlimb
Rabbit tenuissimus
muscle
Rabbit tenuissimus
muscle
Perfused cat
hindlimb
Perfused rabbit
hindlimb

Radioactive
rubidium

25%

75%

Direct observation

75 - 80%

20 - 25%

Direct observation

80%

20%

Radioactive Iodine

60%

40%

Hydrogen

29%

71%
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1.2

PERFUSED HINDLIMB METHODOLOGY
The nutritive/non -nutritive hypothesis has been based most recently on

studies using a constant flow, non -recirculating in situ perfused hindlimb, or isolated
muscle preparations using either cell free, human erythrocyte or bovine erythrocyte
perfusates. Non-physiological conditions, including low oxygen consumption and low
perfusion pressure are the norm for these preparations. Shiota and Sugano (1986)
concluded that the use of an erythrocyte- and albumin-free perfusate in the isolated
perfused rat hindlimb is a useful tool for biochemical investigation into skeletal
muscle function. However, the importance and physiological relevance of using blood
in perfusion when investigating oxygen consumption, tissue function and metabolic
response has been demonstrated in earlier work involving the heart (Topping and
Trimble 1985; Pepe and McLennan 1993) and the liver (Storer et al. 1980) perfusion
systems.
The low perfusion pressure in some models is due to the absence of vascular
tone and therefore they are incapable of vasodilation to increase blood flow. As this
nutritive/non -nutritive theory is related to the provision of oxygen and nutrients for
metabolism, the capacity to va sodilate is important under conditions of high
metabolic rate (that is in contracting muscle). Most of these studies have been
conducted in resting state with no muscle contraction and it is not surprising that
when the hindlimb has been stimulated to contract, the ability of the muscle to
perform over a long duration is poor.
A majority of studies have been performed at 25oC under conditions of
constant flow with a 95% oxygen-5% carbon dioxide gas phase. This type of solution
has low oxygen content (Pepe and McLennan 1993) and leads to oxygen delivery to
the muscle well below that occurring in vivo. With increases in flow rate (decrease in
RBC transit time) it has been shown that hindlimb oxygen consumption increases
reflecting increased oxygen delivery (Figure 1.4) (Ye et al. 1990). It has been
suggested that qualitatively similar changes occur in other studies when the hindlimb
is perfused at 37oC under constant flow with a perfusate using bovine red blood cells
with the same gas phase (Clark et al. 1995).
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Figure 1.4: Adapted from Ye et al. (1990). The effect of flow rate on oxygen consumption and perfusion
pressure in the isolated perfused hindlimb.

At 25 oC cell-free perfusion studies using a perfusion rate of 2 ml ⋅ min-1 (Table
1.5) produce hindlimb perfusion pressures of 21mmHg, with a basal oxygen
consumption of 4.8 µmol ⋅ g-1 ⋅ hr -1 (0.08 µmol ⋅ min -1 ⋅ gww - 1 ) (Colquhoun et al. 1988;
Ye et al. 1990). Higher perfusion rates produce higher perfusion pressures and
increase oxygen consumption (Colquhoun et al. 1988; Colquhoun et al. 1990; Ye et
al. 1990; Dora et al. 1991; Dora et al. 1992; Rattigan et al. 1993; Newman et al.
1996; Newman et al. 1997; Tong et al. 1998). At 8ml ⋅ min-1 and 37oC, cell-free
perfusate perfusion pressure was 37.5mmHg and oxygen consumption was
0.39µmol ⋅ min -1 ⋅ gww - 1 (Vincent et al. 2001b). Using bovine RBC perfusate at 37 oC,
a perfusion rate of 4 ml ⋅ min-1 produced a resting perfusion pressure of 49.5mmHg

and an oxygen consumption of 0.62 µmol ⋅ min -1 ⋅ gww - 1 (Rattigan et al. 1996; Clark et
al. 2001b). All of these perfusion pressures are well below normal in vivo blood
pressure. To achieve physiological perfusion pressure, flow rates of 15-20 ml ⋅ min-1
have been required (Ye et al. 1990). Blood flow through the iliac artery in vivo is
approximately 1.5 ml ⋅ min-1 per vessel (Janiak et al. 2002). Furthermore, increases in
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temperature and oxygen uptake kinetic changes result in a greater rate of diffusion
across the cell membrane. Therefore, the temperature and the presence of
erythrocytes in a perfusate or whole blood may be crucial to the study of in vivo
conditions.

Table 1.5: A comparison of hindlimb flow rates, pressure and oxygen consumption responses from varying
models based upon Ruderman et al. (1971). This table represents a range of studies that have used variations in the
rat hindlimb perfusion method. It is by no means completely comprehensive.

Flow
Rate
2

Perfusate
Temperature
25

Perfusion
Pressure
21

.
Vo 2
0.08

Reference
1

Cell Free
Cell Free

4
8

25
25

27
40

0.13
0.18

2
3

Cell Free

8

37

37

0.39

4

Bovine RBC

4

37

49

0.62

5

Perfusate
Cell Free

Perfusate : perfusion medium used during the perfusion of the hindlimb. Flow Rate: Hindlimb flow
-1
expressed as ml ⋅ min . Perfusate Temperature:
expressed in degrees celsius. Perfusion Pressure: Hindlimb
.
-1
-1
perfusion pressure expressed as mmHg. Vo2 : Hindlimb oxygen consumption expressed as µmol ⋅ min ⋅ gww .
Reference: 1. (Colquhoun et al. 1988; Ye et al. 1990), 2. (Colquhoun et al. 1988; Colquhoun et al. 1990; Dora et al.
1991; Rattigan et al. 1993; Newman et al. 1997; Tong et al. 1998; Ye et al. 1998), 3. (Colquhoun et al. 1988;
Newman et al. 1996), 4. (Vincent et al. 2001b; Clerk et al. 2003), 5. (Rattigan et al. 1996; Clark et al. 2001a; Newman
et al. 2001; Newman et al. 2002)

This thesis uses an autoperfused rat hindlimb with controlled perfusion using
the animal’s own blood and allows for sampling of both arterial and venous blood
(Peoples and McLennan 20 01b, a; Peoples 2004). The animal remains alive
throughout and with intact autonomic nervous system ensuring vascular tone and
maintained perfusion pressure at low perfusion rates. It is believed that this model is
an improved method to provide optimal physiological tissue oxygenation during times
of increased metabolic demand (exercise metabolism) under close to in vivo
conditions.
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1.3

STRUCTURE OF SKELETAL MUSCLE VASCULATURE

1.3.1 Site of Control of Skeletal Muscle Blood Flow
The structure of skeletal muscle vasculature has a vital role in providing
evidence of skeletal muscle dual circulation. It has been shown that no precapillary
sphincters are present in skeletal muscle for the control of capillary perfusion
(Eriksson and Lisander 1972; Eriksson and Myrhage 1972; Lindbom et al. 1980;
Lindbom and Arfors 1985; Ohlen et al. 1988). Skeletal muscle capillary flow is
regulated by the transverse and terminal arterioles and overall muscle blood flow,
and resistance is controlled by large resistance arterioles and small arteries (Figure
1.5) (Lindbom 1983; Sweeney and Sarelius 1989; Anderson and Faber 1991).
Vasoconstriction of the arteriolar vessels during low oxygen tension only extends
down to the first part of the terminal arteriole, which is still a considerable distance
from the branching points of the capillary network (Lindbom et al. 1980). Zweifach
and Metz (1955) defined terminal arterioles as vessels that only have a single layer
of smooth muscle, regardless of the arteriole diameter, in which supporting
connecting tissue elements are almost completely lacking.
Acceptance of non-nutritive flow in skeletal muscle was largely prevented by
the lack of evidence for the location of a discrete route associated with muscle. Such
a route would have the ability to accept high flow and deny nutrient delivery to the
muscle cells but cannot be discriminated by microsphere infusion. The debate over
the existence of true arterio-venous shunts or anastomoses was added to by
Hammersen (1970) who believed that the partial opening and closing (flow
heterogeneity) of “capillary units” (modules) could explain the fast and slow
compartments in skeletal muscle. Hammersen and his colleagues were not
convinced that the vessels in the intramuscular connective tissue could act as true av shunts, so they proposed that these vessels be termed “Bügelkapillaren” or arccapillaries, due to their morphological appearance, rather than their functional
characteristics. These capillaries are usually very long, unramified and extend along
the external surface of the muscle fibre bundles to often join to distal capillary beds or
venules (Hammersen 1968). It was also argued that since these arc-capillaries only
represent 5% of the capillaries studied in the connective tissue sheath they could not
act as true shunts under normal conditions. When fully opened at hyper-perfusion
pressures beyond the normal physiological range, these arc-capillaries could explain
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the circulatory phenomena described under the conditions of previous studies
(Hammersen 1970). A variation in length and degree of branching, different flow
velocities within the capillary, a minor exchange function of non-nutritive vessels or a
shift in perfusion from superficial vessels to deep vessels of the muscle may also
explain the discrepancies Hammersen raised (Vetterlein and Schmidt 1980). From
studies discussed above however, the non-nutritive vessels have a lower resistance
and only 5% of skeletal muscle capillaries would therefore be capable to carry
substantial proportions of total flow.

Connective
Tissue

Muscle
Proximal
Arterioles

Proximal TR

Distal TR

TE

CAP
CAP

Venules

Figure 1.5: Adapted from Borgström et al. (1990) showing a simplified diagram of the microvasculature of the
rabbit tenuissimus muscle illustrating the dual vasculature, muscle and connective tissue. TR: Transverse Arteriole;
TE: Terminal Arteriole; CAP: Capillary Bed.

1.3.2 Capillary Functional Arrangement
Large arterio-venous anastomoses (larger than 20µm) that serve as
functional shunts do not appear to exist in mammalian skeletal muscle (Barlow et al.
1958; Piiper and Rosell 1961). Corrosion casts of the rat gastrocnemius by Potter
and Groom (1983) revealed that capillaries of the rat hindlimb are either 5.5µm or
7.5 µm in diameter, with larger diameter capillaries constituting 17% of total
capillaries. Zweifach and Metz (1955) observed what they termed “metarterioles”
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(non-nutritive routes) along the free edge of the rat spinotrapezius muscle. These
vessels act as shunts to convey the most rapid stream of blood in this muscle. Within
this muscle, capillaries interconnected freely within the connective tissue. In the
rabbit tenuissimus muscle, vascular connections between the transverse arteriole of
the muscle and the associated connective tissue capillaries are a regular and
frequent phenomenon (Lindbom 1983). The connective tissue surrounding the
muscle has vessels ˜ 12µm wide and ˜ 1000µm long running directly from the
transverse arteriole to the transverse venule. These vessels often supply nutrients to
associated adipose tissue but are not arterio -venous anastomoses (Eriksson and
Myrhage 1972). Lindbom and Arfors (1984) reported that 67% of the transverse
arterioles in the tenuissimus muscle of the rat supply the adjacent connective tissue
as well as the muscle tissue proper (Figure 1.5). Lindbom (1986) reported that the
continuation of the transverse arteriole into the connective tissue had only small
luminal changes after vasoactive agent infusion and that this tissue appears to have
little capacity to regulate its own blood supply. In essence, these studies concluded
that non-nutritive vessels have a larger diameter compared to the nutritive vessels
resulting in a resting lower resistance.

1.3.3 Vascular Innervation
Adrenergic innervation of the skeletal muscle microvasculature is largely
limited to the arterial/arteriolar side in close contact with the vessel wall, although
substantial variations of innervation of the precapillary vessels do occur (Baez et al.
1977; Marshall 1982; Saltzman et al. 1992). Nerve plexus density of noradrenergic
and neuropeptide Y neurons (sympathetic neurons) in the spinotrapezius and
cremaster muscles of the rat and tenuissimus muscle of the rabbit are highest in the
transverse and terminal arterioles and are not found in capillaries or venu les (Ohlen
et al. 1988; Fleming et al. 1989). Substance P and calcitonin gene -related peptide
containing perivascular axons innervate large arterioles and arteries, and are likely to
originate from sensory neurons (Fleming et al. 1989; Saltzman et al. 1992).
Furthermore, substance P neurons innervate the transverse arteriole in the
tenuissimus muscle of the rabbit and have been shown to increase blood flo w in a
dose dependent manner (Ohlen et al. 1988), whilst there is an inverse relationship
between arteriolar diameter and sympathetic adrenergic stimulation (Fleming et al.
1987).
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1.3.4 Receptor Location
Skeletal muscle has both α- and β-adrenoceptors which are thought to
regulate metabolism in the cell (Ye et al. 1995). There are two subtypes of αadrenoceptor (α 1- and α 2-adrenoceptors) and three β-adrenoceptors (β1-, β2- and β3 or atop ic-adrenoceptor) (Bowman et al. 1971; Goodman Gilman et al. 1975). The
relationship between skeletal muscle blood flow and α - and β-adrenoceptor
regulation is thought to be brought about by their distribution in the vasculature.
Belfrage (1978) speculated that vascular α-adrenoceptors are primarily located near
nerve endings and β-adrenoceptors (humoral receptor) are situated near the lumen
at some distance from the nerve endings. This would tend to suggest that αadrenoceptors are largely responsive to nervously-released noradrenaline, while the
β-adrenoceptors are mostly influenced by circulating adrenaline.

1.4

BLOOD FLOW REGULATION DURING EXERCISE

1.4.1 General Exercise Blood Flow Phenomenon
Exercise is accompanied by general increases in muscle blood flow and there
is evidence to suggest that this is metabolically regulated at the level of individual
muscle fibres (Berg et al. 1997; Delp and Laughlin 1998). Blood flow to active
skeletal muscle increases in a linear fashion with the increase in oxygen uptake by
muscle cells. This is thought to occur (collectively) through arteriolar vasodilation, the
removal of vasomotion, capillary module recruitment, an increase in capillary
diameter due to elevated transmural pressure and decreased Po 2 (Renkin et al.
1966; Klitzman et al. 1982; Laughlin and Korzick 2001; Slaaf and Oude Egbrink
2002). Arteriolar (resistance vessels) and venular (capacitance vessels) diameter
and capillary perfusion have a positive proportional relationship to the mass of
muscle stimulated and the intensity of the exercise (Kjellmer 1964; Gorczynski et al.
1978). The increase in muscle blood flow at the onset of exercise occurs biphasically
(Kindig et al. 2002). The first phase, hyperaemia, is the mechanical effect of the
muscle pump and vasodilation. The second phase has characteristics of feedback
regulation to match the me tabolic demand (Hughson and Tschakovsky 1999). The
purpose of the first phase is to enhance the coupling of muscle perfusion to muscle
contraction. The recruitment of muscle fibres during the transition into exercise would
necessarily have a relationship with the rapid dilation, and this would be under local
control rather than a change in systemic sympathetic activity.
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Mohrman and Regal (1988) showed that Po 2 and Pco 2 are key variables in
the local control of muscle blood flow during steady state exercise. They concluded
that whilst they did not demonstrate a causal relationship there could be a strong
synergistic effect of Po 2 and Pco 2 that is similar to those found in coronary blood flow
control.
Vascular dependent differences have been found between fast and slow
twitch muscle fibres. At rest, nutritive blood flow can be up to three to six times higher
in soleus muscle than in white gastrocnemius of the cat (Hilton et al. 1970). Glucose
consumption at rest is up to ten times higher in soleus muscle when compared to the
gastrocnemius but decreases in soleus and slightly increases in the gastrocnemius
during contraction (Hudlicka 1975). This is most likely due to differences in metabolic
demand, with the aerobically metabolising red muscle fibres having a higher capillary
density and nutritive flow compared to the anaerobically metabolising white muscle
fibres (Reis et al. 1967).
It is generally assumed that, because arteriolar vasodilation is required to
increase capillary perfusion, and since blood flow and metabolic rate are closely
related and locally regulated (Berg et al. 1997), the rele vant mediators of signalling
between contracting skeletal muscle fibres and the microvasculature will be
vasodilatory metabolites acting directly on small arterioles (Murrant and Sarelius
2000a).

1.4.1.1

Neural Regulation

A classic study by Barcroft et al. (1952) showed that during rhythmic
contractions of the human forearm it was unlikely that the local circulatory response
was facilitated by the inhibition of sympathetic vasoconstrictor activity. In more recent
studies, sympathetic nervous system-mediated vasoconstriction of low metabolic
demand tissue (such as digestive organs) has been characterised as a feature of
exercise whilst acting as a stimulator at other sites (such as the heart). It has been
shown that this sympathetic vasoconstriction can be overcome at the local arteriolar
level through release of vasoactive metabolites such as nitric oxide in both rodents
and awake humans (Chavoshan et al. 2002). Neurally derived nitric oxide plays a
crucial part in vascular changes during mouse hindlimb contraction (Thomas and
Victor 1997; Thomas et al. 1998). Sympathetic nerve activity has a local reflex
response to exercise and metabolic products such as H+ (Hansen et al. 1996). These
metabolic products activate chemically sensitive afferent neurons to increase
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efferent-sympathetic vasoconstrictor activity as a reflex. It is thought that this reflex
(called the muscle metaboreflex) offsets the local metabolic vasodilation to maintain
systemic blood pressure and to limit the reflex increase in blood pressure of
augmented blood flow to the working muscle (Hansen et al. 1994). This sympathetic
vasoconstriction can be negated by metabolic vasodilation thereby increasing oxygen
delivery to active muscle fibres and has recently been termed “functional
sympatholysis” (Segal and Kurjiaka 1995; Hansen et al. 1996).
Sympathetic

vasodilation

can

be

induced

by

either

blockade

of

vasoconstrictor activity or through cholinergic vasodilator neurons in rats, dogs and
cats (Mauskopf et al. 1969). Cholinergic vasodilation has been reported to reduce
oxygen consumption through redistribution of blood into the non-nutritive route
(Rosell and Uvnas 1960). This was contested by Folkow et al. (1961) who reported
that cholinergic vasodilator nerves do not open a non-nutritive route (>20µm),
although in some experimental conditions “functional shunting” could occur through
uneven perfusion of capillaries (Piiper and Rosell 1961). In humans it appears that
sympathetic vasodilator responses could lie with circulating adrenaline or local
cholinergic mechanisms, which stimulate the release of vascular endothelial-derived
nitric oxide (Joyner and Dietz 2003).

1.4.1.2

Vasoactive Metabolites

Vasoactive metabolites, as well as endothelial-derived dilating factors such as
prostaglandins and endothelial-derived relaxing factor (which is believed to be nitric
oxide), are believed to play the major regulatory role in the second phase of
increased skeletal muscle blood flow during exercise. Nitric oxide has been shown to
activate soluble guanylyl cyclase which may contribute to relaxation of the vascular
smooth muscle via cGMP-myosin regulatory light chain cascade (Moncada et al.
1991; Lau et al. 1998). Endothelial-derived dilating factors are released following an
increase in blood velocity and shear stress (Shoemaker and Hughson 1999). Other
endothelial-derived dilating factors such as endothelial-derived hyperpolarising factor
also contribute to endothelium-mediated vasodilation (Laughlin and Korzick 2001).

1.4.2 Mechanisms for Communication of Metabolic Demand
The communication of metabolic demand from the tissue to the sites of
regulation, the transverse and terminal arterioles, has been intensively investigated.
The site for regulating blood flow at metabolically active muscle must be directly
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upstream from the active cells because metabolite release into the circulation would
produce a generalised whole body response. The main mechanism for blood flow
regulation is produced by the release of vasodilatory agents. Evidence suggests that
capillaries can act as a communicating medium that can sense and integrate
biological signals but the mechanism for this upstream communication has yet to be
defined (Song and Tyml 1993). So it has been hypothesised that upstream
communication via cell-to-cell coupling, or periarteriolar neural pathways collectively
called “conducted vasomotor response”, could be the possible mechanisms by which
metabolites released from the active skeletal muscle cells might selectively influence
blood flow to those same cells (Gustafsson and Holstein -Rathlou 1999). Although
calcium-dependent spikes can mediate neural conduction, periarteriolar neural
pathways were ruled out as a possible mechanism when tetrodotoxin (TTX, a
selective Na + channel blocker), papaverine (phosphodiesterase inhibitor) and various
calcium

antagonists

were

infused

failed

to

modify

propagated

upstream

vasodilatation (Ohlen et al. 1988; Fleming et al. 1989; Segal and Duling 1989;
Dietrich and Tyml 1992b).

In short, it appears that skeletal muscle blood flow is regulated by multiple
mechanisms. During exercise , metabolic vasodilation and increased vascular
conductance through the skeleta l muscle pump seem to be the primary mechanisms.
Modulation of these mechanisms could be dependent on other factors such as
endothelial derived nitric oxide and PGI2 (Delp and Laughlin 1998).
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1.5

AIMS & HYPOTHESES
This thesis aimed to test the hypothesis that skeletal muscle beds contain

alternate parallel vascular pathways that can be controlled to redistribute blood flow
during active metabolism.
We aimed to:
(a) Establish selective vasoconstriction (seen before in in-vitro),
(b) Establish selective vasodilation (vasodilator metabolites most likely to
influence local blood flow with increased metabolic activities),
(c) Establish that distribution is altered during active metabolism.

It has been proposed that there are alternative vascular pathways within
skeletal muscle that enable high blood flow to be directed to the muscle cells when
they are active (so called nutritive pathway) and to bypass the muscle cells when
they are inactive (non-nutritive pathway).
While the nutritive/non-nutritive circulation is an attractive hypothesis to
explain control of blood flow to metabolising tissue, it has been largely defined in
terms of vasoconstrictors. In contrast, local control of blood flow during increased
metabolism has been largely described in terms of vasodilatory metabolites released
from the active tissue. That is, an active muscle cell can produce metabolites that will
selectively increase perfusion to that muscle.
Furthermore, while purporting to explain metabolically regulated blood flow,
the nutritive/non -nutritive hypothesis is based entirely on studies using noncontracting skeletal muscle (tissues of low metabolic demand). These perfused
hindlimb or isolated muscle preparations exhibit low vascular tone, and being
incapable of vasodilation to increase blood flow and inevitably produce extremely low
blood pressure. They are also limited by their low oxygen delivery and are unable to
provide data on the relationship of oxygen consumption to muscle activity. Since this
is a theory relating to the provision of oxygen for metabolism, the capacity to
vasodilate is important under conditions of high metabolic rate, that is, in contracting
muscle. We proposed to use an autoperfused hindlimb method. This technique uses
an anaesthetised animal, with its own blood allowing for high oxygen delivery
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provided to the hindlimb skeletal muscle. This method further allows for the retention
of vascular tone aiding in the study of muscle contraction and oxygen use and the
influence of drugs that affect the blood vessels supplying the muscle.
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2

CHAPTER TWO

Methods and Materials
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2.1

ANIMALS
Male Hooded Wistar rats (weight 450~785g) were obtained from Gore Hill

Animal Research Laboratory (Royal North Shore Hospital, Sydney) and were housed
(2 per cage) in the University of Wollongong animal house. Animal house
environmental conditions were controlled with room temperature maintained at 23 oC25 oC and a 12 -hour light/dark cycle. Animals were used and cared for according to
the National Health and Medical Research Council guidelines for the care and
maintenance of laboratory animals and were fed on a commercial chow-diet adlibitum with water freely available. All experimental procedures were approved by the
Animal Ethics Committee of the University of Wollongong.

2.2

ANIMAL ANAESTHESIA

Animals were anaesthetised before the commencement of surgical
procedures with sodium pentobarbital (6 mg ⋅ 100g -1 body weight i.p.). Anaesthesia
was maintained with supplementary injections (2 ml ⋅ 100g-1 i.p.) as required during
surgery and protocols. Experiments were performed in a heated perspex chamber, with
animal body temperature maintained with the aid of a heating lamp placed above the
rat.

2.3

CALIBRATION OF EQUIPMENT
Pressure and force transducers were calibrated immediately prior to each

hindlimb perfusion. Pressure transducers were calibrated against a mercury
sphygmometer in the range of 0-300mmHg. The force transducer was calibrated
using standard calibration weights in the range of 0-200g (HB Selby and Co Ltd.
Sydney). An amp meter (Testmate 308) was used to read voltage output for
calibration of computer data acquisition.
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Figure 2.1: Surgical cannulations redirect and regulate arterial blood flow in the rat from the control to the
perfused hindlimb. Venous blood flow is returned passively to the heart via the jugular vein for re-oxygenation by the
lungs. Stimulator attached to the sciatic nerve. Gastrocnemius-plantaris-soleus muscle bundle attached to the Grass
force transducer.
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2.4 SURGICAL PREPARATION FOR BLOOD FLOW,
VENTILATION AND MUSC LE STIMULATION.
2.4.1 Ventilation and Blood Flow
2.4.1.1

Ventilation and Systemic Blood Pressure

The animal was shaved across both hindlimbs, the abdominal region and
anterior neck. A tracheotomy was performed using a polyethylene tube allowing the
animal’s breathing to be maintained by artificial ventilation, thereby ensuring that the
level of oxygen in the arterial blood remained high and constant during each
experiment (Figure 2.1). The animal was connected to a rodent ventilator (7025, Ugo
Basile, Italy) and the stroke volume was set according to animal body weight
( 1ml ⋅ 200g-1 ).
A cannula was inserted into the left common carotid artery and connected to
a pressure transducer (Argon CDXIII, Maxxim Medical, USA) for direct measurement
of systemic blood pressure. All cannulae (Dural Plastics, Internal Diameter 0.58mm
Outside Diameter 0.96mm) were fluid filled with isotonic saline containing 6%
Dextran 70 (w/v) and Heparin 5000 IU.100ml -1.

2.4.1.2

Arterial blood flow

A cannula was inserted into the right femoral artery (non-perfused leg)
towards the heart for direct access to oxygenated arterial blood from the descending
aorta. This cannula was connected to peristaltic pump tubing (Gilson, France,
2.50cc/m), passed through a peristaltic roller pump (Miniplus 3, Gilson, France) and
connected to a cannula that was inserted into the left femoral artery (perfused leg)
towards the foot. The cannula was passed well down the femoral artery towards the
knee to close off unwanted side branches and restrict perfusion to the muscle beds
of the lower hindlimb. Other side branches were ligated. A T-junction inserted in the
blood flow line on the perfused hindlimb side of the pump was connected to a
pressure transducer for measurement of hindlimb perfusion pressure. A Windkessel
pressure dampener was inserted into the blood flow line to reduce large pulsatile
changes in pressure, such as that occurring as the pump was started.
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2.4.1.3

Venous blood flow

A fluid filled cannula (Internal Diameter 0.58mm Outside Diameter 0.96mm)
was inserted into the left femoral vein towards the foot of the perfused leg with the
other end inserted in the right external jugular vein for passive venous return to the
heart and lungs for re-oxygenation.
When all cannulae were in place, passive flow was allowed through the pump
from the right femoral artery of the non-perfused hindlimb to the left femoral artery of
the perfused hindlimb. When all tubes had filled with the animal’s own blood ≈
(1
minute) the pump was engaged to provide a constant flow rate of 1 ml ⋅ min-1 through
the hindlimb vasculature. All hindlimbs were then perfused for 30 minutes at
1 ml ⋅ min-1 to allow for mean perfusion pressure to reach steady state (≈100mmHg).
During these setting up procedures the perfused hindlimb was hypoxic for less than 2
minutes. Previous studies have demonstrated that the catheter diameter has no
adverse affect upon venous pressure as measured by foot volume (Peoples 2004).

2.4.1.4

Nerve and muscle isolation

The rat was turned onto its right side and a small incision was made in the
skin, 1cm below the iliac crest. The gluteal muscles were separated to expose the
sciatic nerve trunk. A bipolar electrode (Grass Instrument Division, USA) was placed
under the nerves for direct electrical stimulation of the trunk supplying the muscles of
the gastrocnemius-plantaris-soleus muscle bundle. Saline-soaked gauze was placed
over the incision to prevent drying of the nerve.
The animal was then turned onto its back and the left leg was secured at the
knee and foot to prevent movement during stimulation. The gastrocnemius-plantarissoleus muscle group tendons were tied with non-stretch silk and connected to a force
transducer (FT03C, Grass Instrument Division, USA). Saline -soaked gauze was
placed over the muscle tendons to prevent them from drying.

2.4.2 Muscle Stimulation
For muscle contraction protocols, after the initial 30 minutes equilibrium, the
peristaltic pump speed was increased to 2 ml ⋅ min -1 and stimulation of sciatic nerve of
the perfused hindlimb commenced at 5Hz for 3 minutes.
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2.5 COLLECTION OF BLOOD PRESSURE AND TWITCH
FORCE
Data was referenced to ground and amplified (Onspot Australia). Data
acquisition software, Labview for Windows (National Instruments), was used to
collect both pressure and twitch force simultaneously during the perfusion protocols
at a sampling rate of 200Hz. The data was displayed in real time and stored on
computer for later analysis.

2.5.1 Calculation of Oxygen Consumption
Oxygen consumption was assessed according to the Fick equation and
adjusted for muscle mass:
Oxygen consumption =

(a-v)O2 diff × (hindlimb flow rate)
Weight of perfused muscle

Where:
O2 consumption expressed in µmol ⋅ min-1 ⋅ gww -1 .
(a-v)O 2 diff : the arterial – venous oxygen difference expressed in µmol ⋅ ml-1.

Hindlimb flow rate: expressed in ml ⋅ min-1 .
Weight of contracting muscle: expressed in grams wet weight (gww).

Arterial and venous oxygen content (ml.100ml -1) was calculated using:

Oxygen content = (1.39 x Hb x RBC saturation (%))+(0.003 x Po 2)

Where:
1.39 = millilitres of oxygen bound to 1 gram haemoglobin.
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Hb: blood haemoglobin concentration expressed in g.100ml -1.
RBC saturation (%): percentage of the haemoglobin that is saturated with
oxygen calculated using measured Po 2, Pco2 and pH for blood specific P 50.
Po 2: partial pressure of oxygen in whole blood expressed in mmHg
0.003 = constant for dissolved oxygen in plasma at 38oC.

2.5.2 Collection of Blood Samples and Muscle Tissue
2.5.2.1

Blood

Arterial and venous blood was sampled (100 µl) from the arterial input and
venous output lines of the hindlimb through in-line, thick walled, self-sealing silicone
tubing. Measurement of pH, Po2, Pco 2, haematocrit (Hct), K+, and haemoglobin were
performed using a blood gas and electrolyte analyser (ABL77 Radiometer,
Copenhagen) using 70µl of sampled blood. The remaining sample volume was resuspended in an equal volume of heparinised isotonic saline (1:1 heparin to saline)
and re-injected into the venous side of the perfusion so as to maintain haemoglobin
levels above 12.5 g.100ml-1 whole blood throughout the whole experiment.

2.5.2.2

Muscle

At the completion of each experiment, muscles from the perfused hindlimb
were collected to establish total weight of the muscle involved in the perfusion.
Muscles sampled were gastrocnemius, plantaris, soleus, deep posterior tibial,
extensor digitorum longus, and tibialis anterior.

2.6

PROTOCOLS

2.6.1 Infusion of Drugs
Agonist drugs were infused in a constant volume (0.2ml) into the arterial
perfusion through the self-sealing silicon tubing. Drugs were infused in an increasing
molar dose sequence with a 10 minute rest period in between doses to allow for
washout (natural clearance or uptake processes) to occur.
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2.6.2 Basal Protocol
2.6.2.1

Resting

One arterial and two venous blood samples were taken at the end of the 30
minute equilibrium perfusion to determine resting hindlimb oxygen consumption. To
test the effects of the vehicle on hindlimb pressure and oxygen consumption, 0.2ml
saline was infused in the arterial perfusion with venous sampling as described below.

2.6.2.2

Arterial

Arterial sampling occurred an average of 3-4 times during the course of an
experiment. With the aid of the rodent ventilator, arterial haemoglobin saturation and
oxygen content remained consistent throughout the experiment.

2.6.2.3

Venous

During the resting protocols, venous sampling occurred at 2, 3, 4 and 5
minutes after infusion of an agonist. Without continuous recordings of oxygen
consumption, it was anticipated that maximal change would be seen in one of the
four samples.

2.6.3 Contraction Protocol
2.6.3.1

Contracting muscle

At the end of the 30 minute equilibrium perfusion muscle stimulation
commenced as described above (see 2.4.2 muscle stimulation). One arterial and two
venous blood samples were taken to determine contracting hindlimb oxygen
consumption. To test the effects of the vehicle on hindlimb pressure and oxygen
consumption, 0.2ml saline was infused in the arterial perfusion with venous sampling
as described below. After 3 minutes, pump speed was returned to 1 ml ⋅ min-1 and
muscle stimulation terminated. A minimum of 10 minutes of resting perfusion was
allowed between protocols to reduce the likelihood of fatigue and to allow for drug
washout. Figure 2.2 shows a time line for events during this protocol.
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2.6.3.2

Venous

The agonist drug was infused 10 seconds after the commencement of the
hindlimb stimulation and after achievement of maximum peak tension. Venous
sampling occurred 2.5 minutes and 3.5 minutes after infusion of a drug.

0min 10s
Infuse drug
2 ml ⋅ min -1
Start Stim. 5Hz

2.5min

3min 3.5min
1 ml ⋅ min -1
Finish Stim

Figure 2.2: Time line of events for the contraction protocol. Arrow represents venous blood sampling (100µl).

2.7

STATISTICAL ANALYSIS
Results are expressed as mean ± SEM. All statistics were performed using

paired Student’s t–test in Microsoft Excel (Microsoft Corporation, USA). A probability
value of P < 0.05 was considered to be significant. Mean perfusion pressure was
determine by the mean of 3 pump cycles.
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2.8

DRUGS AND CHEMICALS
Saline was made up in stock solution (0.9% NaCl) and used at room

temperature. Dextran 70 (Sigma-Aldrich Diagnostics, Sydney) was dissolved in the
prepared saline (6% by weight) at room temperature 24 hours prior to use. Heparin
was dissolved fresh daily (5000 IU ⋅ 100ml-1 ) to solution.

All drugs were prepared at a 10mM stock with isotonic saline and 0.1%
ascorbic acid (Sigma -Aldrich Diagnostics, Sydney), and stored at –18 oC in 1ml
eppendorf tubes. Drugs were prepared fresh before each protocol using defrosted
stock and isotonic saline.

Drugs
Hydrochloride,

used

were

(-+)-Arterenol

(+ -)-Isoproterenol

Hydrochloride,

Hydrochloride,

5-Hydroxytrypyamine

Adenosine

Hemisulphate,

Nifedipine, Bradykinin Acetate, Hydralazine Hydrochloride, Sodium Nitroprusside
Dihydrate, Histamine Diphosphate, and Acetylcholine Chloride. These were all
supplied by Sigma -Aldrich, Sydney.
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CHAPTER THREE

Results
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3.1

MODEL AND VEHICLE

3.1.1 Model
3.1.1.1

Blood Profile

The autoperfused rat hindlimb was developed as a model that could provide
oxygen delivery within an in vivo range at in vivo vascular resistance in both resting
and contracting muscle for the study of skeletal muscle function and metabolism.
Arterial blood pH (7.3 to 7.5) and haemoglobin (14 to 16 g ⋅ 100ml-1 ) were maintained
within the normal range both under basal conditions and during muscle contraction
(Table 3.1) (Spector 1956; Altman and Dittmer 1974). Arterial blood oxygen tension
(Po 2) (90 to 100mmHg) and arterial blood carbon dioxide tension (Pco2) (35 to
45mmHg) were also maintained in the normal range. Venous Po 2 was significantly
lower than arterial Po 2 both during contraction and at rest. Venous Po 2 (40 to
50mmHg) and venous Pco 2 (45 to 55mmHg ) were also within the normal range
(Spector 1956; Tuttle and Schottelius 1969; Altman and Dittmer 1974), as was
arterial oxygen saturation of haemoglobin (So 2) (92.5-98.5%) and venous So2 (65 to
75%) (Spector 1956; Marshall et al. 1962; Altman and Dittmer 1974). The
haematocrit and Po 2 maintaining high haemoglobin O2 saturation ensuring that
g

arterial oxygen content ([ V O2 ]a) was also maintained within the normal range of 18.8
g

to 23 ml ⋅ 100ml-1 as was the venous O2 content ([ V O2 ] v,15.9 to 17.5 ml ⋅ 100ml-1 )
(Spector 1956; Altman and Dittmer 1974; Pepe and McLennan 1993). The resulting
basal (a-v)O 2 diff was 4.98 ± 0.41 ml ⋅ 100ml-1 (n = 75) whilst the contraction
-1
(a-v)O2 diff was 3.99 ± 1.00 ml ⋅ 100ml (n = 20).
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Table 3.1: Blood profile of experimental animals for both arterial and venous blood circulated to and from the
perfused hindlimb.

Arterial
n

Venous

Basal

Contraction

Basal

Contraction

55

10

75

20

pH

7.37 ± 0.01

7.39 ± 0.01

7.27 ± 0.01 *

7.29 ± 0.01 *

Pco2 (mmHg)

34.7 ± 0.8

34.4 ± 1.1

51.4 ± 1.1 *

50.6 ± 1.5 *

Po 2(mmHg)

102.1 ± 1.6

88.7 ± 5.2

46.3 ± 1.5 *

45.4 ± 2.5 *

Hct (%)

45.4 ± 0.5

47.5 ± 1.3

47.1 ± 0.4

49.8 ± 0.9

Hb ( g ⋅ 100ml-1 )

14.8 ± 0.2

15.5 ± 0.4

15.4 ± 0.1

16.3 ± 0.3

So 2 (%)

97.6 ± 0.1

95.9 ± 1.1

71.2 ± 1.8 *

71.7 ± 3.7 *

20.4 ± 0.2

20.8 ± 0.4

15.4 ± 0.4

16.3 ± 0.7

3.7 ± 0.1

3.8 ± 0.1

3.3 ± 0.1

3.7 ± 0.1

g

[ V O2 ] ( ml ⋅ 100ml-1)
K+ ( mmol ⋅ l-1 )

Mean ± SEM Significant from arterial represented by * (P < 0.05)

3.1.1.2

Perfusion Pressure

The autoperfused hindlimb had no significant effect on mean systemic blood
pressure during both protocols. The mean systemic blood pressure at a hindlimb
perfusion rate of 1 ml ⋅ min-1 for the basal protocol was 85 ± 2mmHg (n = 44) and
when the flow rate was increased to 2 ml ⋅ min-1 during the contraction protocol, mean
systemic blood pressure remained stable at 79 ± 6mmHg (n = 8) (Figure 3.1). At a
basal flow rate of 1 ml ⋅ min -1 the mean hindlimb perfusion pressure was 92 ± 3mmHg
which was increased to 166 ± 6mmHg when the flow rate was increased to
2 ml ⋅ min-1 for the contraction protocol.
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200

Mean Pressure
(mmHg)

150

100

50

0

1ml.min-1

2ml.min-1

Figure 3.1: Mean blood pressures at hindlimb perfusion rates of 1 or 2 ml ⋅ min -1 . Filled bars (n = 44)
represents hindlimb perfusion pressure. Hatched bars (n = 8) represents mean systemic blood pressure.

3.1.1.3

Oxygen Consumption

.
consumption
(V o2)
was
0.33 ±
.
-1
-1
0.02µmol ⋅ min ⋅ gww (n = 74) (Figure 3.2). Mean V o2 was significantly reduced to
The

mean

basal

oxygen

0.19 ± 0.03 µmol ⋅ min -1 ⋅ gww -1 (n = 20) when flow rate increased to 2 ml ⋅ min -1
without contraction. However this was significantly increased to 0.57 ±
0.08µmol ⋅ min -1 ⋅ gww - 1 (n = 20) during the contraction protocol (2 ml ⋅ min-1 with
hindlimb stimulation).

*

0.7

-1

-1

(µmol.min .gww )

Oxygen Consumption

0.6
0.5
0.4
0.3

*

0.2
0.1
0.0

1ml.min -1
No Contraction

2ml.min -1
Contraction

Figure 3.2: The effect of flow and hindlimb muscle contraction upon oxygen consumption in the autoperfused
hindlimb. Significance from basal at 1 ml ⋅ min

-1

flow rate represented by * (P < 0.05).
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3.1.1.4

Force of Contraction

The maximal rate of force development (+dT/dtmax) and maximal rate of
relaxation (-dT/dtmax) was recorded to observe any changes after agonist infusion that
would limit substrate delivery through blood flow redistribution within the muscle
during the contraction protocol. The mean force production was 0.15 ± 0.01N (14.8 ±
2.1g) and a +dT/dtmax of 10.2 ± 1. 3 N ⋅ s-1 and a -dT/dtmax of -9.4 ± 1.4 N ⋅ s-1 (n = 8).
The mean peak force production (T max) was 0.24 ± 0.02N (24.2 ± 3.4g, n = 8). Figure
3.3 shows an example trace of the hindlimb force developed during the contraction
protocol.
0.25

Change in Force
(N)

0.20
0.15

-dT/dt max

T max

0.10

+dT/dt max
0.05
0.00
0.05

0.10

0.15

0.20

0.25

-0.05
Time (s)

Figure 3.3: An example trace of a single twitch during the contraction protocol. Sample rate was 200Hz.
+dT/dt max: maximal rate of force development; -dT/dtmax : maximal rate of relaxation; Tmax : mean peak force
production

3.1.2 Vehicle
3.1.2.1

Perfusion Pressure

Basal mean pre -infusion hindlimb perfusion pressure was 98 ± 9mmHg
(1 ml ⋅ min -1 ) and contraction was 168 ± 9mmHg (2 ml ⋅ min -1 ). Hindlimb perfusion
pressure was significantly decreased following the infusion of the saline vehicle
under basal (1 ml ⋅ min-1 hindlimb flow, see Figure 3.5) or contraction (2 ml ⋅ min-1, see
Figure 3.7) flow rates. The effect was short lived and by the time of peak drug effect
(90s, see Figure 3.4 and 3.6) had returned to baseline (Figure 3.4). There was no
significant effect on mean systemic blood pressure after the infusion of the vehicle.
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Maximal

90s

Change in Perfusion Pressure
(mmHg)

0

-10

-20

-30

*

-40

*

-50

Figure 3.4: Summary of the maximal effect and the effect 90 seconds post -infusion of the vehicle saline on
mean hindlimb perfusion pressure during basal (filled bars, n = 6) and contraction (clear bars, n = 8) protocols.
Significance from pre-infusion perfusion pressure represented by * (P < 0.05).

Hindlimb Perfusion Pressure
(mmHg)

125

100

75

50

25

0

Systemic Blood Pressure
(mmHg)

125

100

75

50

25

0
0

50

100

150
200
Time (s)

250

300

350

Figure 3.5:

An example trace of hindlimb perfusion pressure and systemic blood pressure after saline infusion.
The black arrow indicates the saline effect.
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3.1.2.2

Oxygen Consumption

.
Prior to vehicle or agonist infusion the mean basal hindlimb Vo 2 was 0.50 ±
.
0.06µmol ⋅ min -1 ⋅ gww - 1 (n = 6), whilst mean contraction hindlimb Vo 2 was 0.49 ±
.
0.09µmol ⋅ min-1 ⋅ gww -1 (n = 17). Basal V o2 was not significantly affected following
.
infusion of saline vehicle, although V o2 was significantly decreased during the
contraction protocol (Figure 3.6).

At all perfusion rates the effect of the vehicle (saline) on all parameters was
nullified by recording the effects of the drug after the effect of the vehicle had been
completed (see Figures 3.8, 3.9, 3.10 and 3.11).

0.10

-1

-1

(µmol.min .gww )

Change in Oxygen Consumption

0.15

0.05
-0.00
-0.05
-0.10
-0.15
-0.20
-0.25

*
Basal

Contraction

Figure 3.6: Summary of the effect of the vehicle saline on oxygen consumption during basal (filled bars, n = 6)
and contraction (clear bars, n = 17) protocols. Significance from pre -infusion oxygen consumption represented by * (P
< 0.05).
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0.25

Change in Force
(N)

0.20

0.15

0.10
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0.00

Hindlimb Perfusion Pressure
(mmHg)
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50

0

Systemic Blood Pressure
(mmHg)

200

150

100

50

0
0

50

100

150
Time (s)

200
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Figure 3.7: An example trace of hindlimb twitch; hindlimb perfusion pressure and systemic
blood pressure
-1
during saline infusion. The shaded section indicates when the pump speed was 2 ml ⋅ min . The black arrow
indicates the saline effect.
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The following figures (3.8, 3.9, 3.10, and 3.11) show typical basal and
contraction pressure recordings of both systemic blood pressure and hindlimb
perfusion pressure during agonist infusion. The injection artefact of the saline vehicle
and the measurement of mean perfusion pressure are shown.

Hindlimb Perfusion Pressure
(mmHg)

350
300
250
200
150
100
50
0

Systemic Blood Pressure
(mmHg)

350
300
250
200
150
100
50
0
0

50

100

150

200

250

300

350

Time (s)

Figure 3.8:

An example trace of hindlimb perfusion and systemic blood pressure during Noradrenaline infusion.
The white arrow indicates the time when the drug effect was sampled.
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Figure 3.9: An example trace of hindlimb twitch; hindlimb perfusion pressure and systemic blood pressure

during Serotonin infusion. The shaded section indicates when the pump speed was 2 ml ⋅ min -1 . The black arrow
indicates the saline effect and the white arrow indicates the time when the drug effect was sampled.
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Figure 3.10: An example trace of hindlimb perfusion pressure and systemic blood pressure during Histamine
infusion at rest. The black arrow indicates the saline effect and the white arrow indicates the time when the drug
effect was sampled.

It is important to note that the vasoconstrictor-induced increase in mean
hindlimb perfusion pressure (Figure 3.8 and 3.9) could possibly have been greater
without the injection artefact of the saline vehicle. There was no significant effect by
the infusion of the agonists or vehicle alone on systemic blood pressure.
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Figure 3.11: An example trace of hindlimb twitch; hindlimb perfusion pressure and systemic-1 blood pressure

during Isoprenaline infusion. The shaded section indicates when the pump speed was 2 ml ⋅ min . The black arrow
indicates the saline effect and the white arrow indicates the time when the drug effect was sampled.
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3.2

VASOCONSTRICTORS

3.2.1 Basal Protocol
3.2.1.1

Perfusion Pressure

The Type A (noradrenaline, NAd) and Type B (serotonin, 5-HT)
vasoconstrictors were studied in this model, in resting and contracting hindlimb.
Under restin g conditions, there was a threshold observed with noradrenaline, with
dose -dependent effects seen above 16 µM (Figure 3.12). Mean pre-infusion hindlimb
perfusion pressure for the low dose noradrenaline (100nM – 1.6µM) was 80 ±
5mmHg (n = 3) and for the high dose noradrenaline (1 µM – 256µM) was 87 ±
2mmHg (n = 6). Low dose noradrenaline and two high dose noradrenaline doses
(1µM and 4µM) had no significant effect on mean hindlimb perfusion pressure.

There was a dose-dependent increase in mean hindlimb perfusion pressure
after serotonin administration (Figure 3.13). Mean pre -infusion hindlimb perfusion
pressure for serotonin was 80 ± 2mmHg (n = 6) and was significantly increased for all
doses screened. There was a linear relationship between serotonin and perfusion
pressure until 50µM after which the vasoconstrictor effect on perfusion pressure was
reduced. 50µM serotonin maximally increased mean hindlimb perfusion pressure by
171 ± 21mmHg whilst at 100µM serotonin increased perfusion pressure was 3% less
than 50µM during basal conditions.
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Change in Oxygen Consumption
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Figure 3.12: The effect of Noradrenaline on hindlimb perfusion pressure and oxygen consumption. The effect

of low dose (basal n, n = 3, contraction £, n = 6) and high dose (basal p, n = 6, contraction r, n = 3) Noradrenaline
infusion on perfusion pressure and oxygen consumption during basal and contraction conditions. Significance from
pre -infusion represented by * (P < 0.05).

3.2.1.2

Oxygen Consumption

Changes in hindlimb oxygen consumption are thought to be associated with
.
redistribution of hindlimb muscle blood flow. The mean pre -infusion Vo 2 for low dose
noradrenaline was 0.47 ± 0.04 µmol ⋅ min -1 ⋅ gww - 1 (n = 3) and high dose
noradrenaline was 0.48 ± 0.06 µmol ⋅ min-1 ⋅ gww -1 (n = 6). There was no significant
.
effect observed for all doses of noradrenaline on hindlimb V o2 during the basal
protocol (Figure 3.12).
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After serotonin infusion, there was a significant dose-dependent effect on
.
hindlimb oxygen consumption (Figure 3.13). The mean pre-infusion hindlimb V o2 for
serotonin was 0.57 ± 0.06 µmol ⋅ min-1 ⋅ gww -1 (n = 6). Serotonin significantly
.
decreased hindlimb Vo2 for all doses screened (12.5 – 100µM) but the magnitude of
the effect did not increase with increasing dose. Maximal effect of serotonin on
.
hindlimb Vo 2 was to reduce it by 0.40 ± 0.09 µmol ⋅ min-1 ⋅ gww -1 at 25 µM, but at
.
100µM Vo 2 was reduced by 0.35 ± 0.08 µmol ⋅ min -1 ⋅ gww - 1 .
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Figure 3.13: The effect of Serotonin on mean hindlimb perfusion pressure and oxygen consumption during
basal (˜) and contraction (™) protocols. Significance from pre-infusion represented by * (P < 0.05). n = 6
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3.2.2 Contraction Protocol
3.2.2.1

Perfusion Pressure

Mean pre-infusion hindlimb perfusion pressure during muscle contraction for
low dose noradrenaline was 150 ± 5mmHg (n = 6) and for high dose noradrenaline
was 202 ± 2mmHg (n = 3). After noradrenaline infusion during the contraction
protocol, a threshold was observed similar to the basal threshold on mean hindlimb
perfusion pressure (Figure 3.12). Low dose noradrenaline had no significant effect,
except for 1.6 µM, whilst high dose noradrenaline significantly increased hindlimb
perfusion pressure at 16µM and 64µM only.

Serotonin infusion significantly increased perfusion pressure for all doses with
a similar dose-dependen t trend as seen during the basal protocol (Figure 3.13). The
mean pre-infusion hindlimb perfusion pressure for serotonin was 148 ± 4mmHg (n =
6). Serotonin maximally increased perfusion pressure by 163 ± 15mmHg at 50µM
with higher doses producing a slightly diminished effect upon hindlimb perfusion
pressure

3.2.2.2

Oxygen Consumption

.
Low dose noradrenaline infusion had no significant effect on V o2 during the
.
contraction protocol whilst high dose noradrenaline significantly decreased Vo 2
.
(Figure 3.12). Mean pre-infusion Vo 2 for low dose noradrenaline was 0.52 ±
0.07µmol ⋅ min-1 ⋅ gww -1 (n = 6) and for high dose noradrenaline was 1.14 ± 0.38
.
-1
-1
µmol ⋅ min ⋅ gww (n = 3), which was 3-fold higher than the mean contracting Vo 2 of
0.57 ± 0.08 µmol ⋅ min-1 ⋅ gww -1 (n = 20).

.
Serotonin significantly decreased V o2 in a dose -dependent manner during the
contraction protocol with a similar trend to that observed during the basal protocol
.
(Figure 3.13). Pre-infusion hindlimb Vo2 for serotonin was 0.59 ±
.
0.11µmol ⋅ min-1 ⋅ gww -1 (n = 6). The maximal change observed in hindlimb Vo 2 was
0.30 ± 0.11 µmol ⋅ min -1 ⋅ gww - 1 (46%) at 25µM (n = 6). This was the only dose of
.
serotonin to have a significant effect on hindlimb Vo 2 during the contractio n protocol.
.
During the basal protocol, 25µM serotonin induced a 67% decrease in Vo 2 compared
to only a 46% decrease during the contraction protocol (Figure 3.14). During
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.
.
contraction 100 µM 5-HT produced a 64% (P = 0.054) reduction in Vo 2 from Vo 2 at
rest (Figure 3.15).
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Figure 3.14: The percentage difference of the effect of Serotonin on oxygen consumption during basal (filled)

Oxygen Consumption as a Percentage
of Basal

and contraction (clear). Significance from pre-infusion oxygen consumption represented by * (P < 0.05). n = 6
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Figure 3.15: The percentage difference between contraction and basal protocols during Serotonin infusion on
oxygen consumption. n = 6
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3.2.2.3

Force of Contraction

Skeletal muscle contraction could be diminished if vasoconstrictor infusion
limited substrate delivery through blood flow redistribution within the muscle. No
significant effects were observed on either +dT/dtmax or -dT/dtmax after either low dose
or high dose noradrenaline infusion (Figure 3.16). Mean pre-infusion +dT/dtmax was
13.3 ± 0.7 N ⋅ s-1 for low dose noradrenaline (n = 6) and 9.6 ± 0.6 N ⋅ s-1 for high dose
noradrenaline (n = 6). Low dose noradrenaline had a mean pre -infusion -dT/dtmax of
-8.0 ± 0.5 N ⋅ s-1 and high dose noradrenaline was -7.4 ± 0.5 N ⋅ s-1 .

Maximal Rate of Contraction
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Figure 3.16: The effect of Noradrenaline on maximal rate of contraction (low dose: £, n = 3; high dose: r, n =
6) and relaxation (low dose: ¢; high dose: p) during muscle contraction. The dashed line indicates pre-infusion
maximal rate of contraction and relaxation. Significance from pre-infusion represented by * (P < 0.05).

Serotonin infusion had no significant effect on either +dT/dtmax or -dT/dtmax in
the autoperfused hindlimb (Figure 3.17). Mean pre-infusion +dT/dtmax was 12.4 ±
1.8 N ⋅ s-1 with a mean pre-infusion -dT/dtmax of -8.7 ± 0.8 N ⋅ s-1 (n = 4). The maximal
effect of serotonin was observed at 50µM, which resulted in +dT/dtmax increasing to
22.3 ± 3.3 N ⋅ s -1 and -dT/dtmax to -18.9 ± 4.1 N ⋅ s -1 .
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Figure 3.17: The effect of Serotonin on maximal rate of contraction (£) and relaxation (¢) during muscle
contraction. The dashed line indicates pre-infusion maximal rate of contraction and relaxation. Significance from preinfusion represented by * (P < 0.05). n = 4

Generally noradrenaline had a dose-dependent threshold of 16µM on
perfusion pressure during both basal and contraction protocols (Figure 3.18).
Noradrenaline had no significant effect on oxygen consumption during basal
conditions whilst hindlimb oxygen consumption decreased during hindlimb
stimulation (Figure 3.19). The pre-infused oxygen consumption during the contraction
protocol was two times greater than the mean contraction hindlimb oxygen
consumption (Table 3.2).

Table 3.2: Summary of the greatest effects of vasoconstrictors on perfusion pressure and oxygen consumption
in the autoperfused rat hindlimb.

Drugs

Protocol

n

Perfusion
Pressure
(mmHg)

.
V o2
( µmol ⋅ min-1 ⋅ gww -1 )
i 0.13 ± 0.06

L.D Noradrenaline

Basal

3

i 4±2

H.D. Noradrenaline

Basal

6

*h 216 ± 6

i 0.23 ± 0.17

Serotonin

Basal

6

*h 171 ± 21

*i 0.40 ± 0.09

L.D Noradrenaline

Contraction

6

h 14 ± 6

h 0.33 ± 0.18

H.D. Noradrenaline

Contraction

3

*h 198 ± 15

*i 1.13 ± 0.47

Serotonin

Contraction

6

*h 163 ± 15

*i 0.30 ± 0.11

Mean ± SEM.

hi

denotes trend, Significance from pre-infusion represented by

*h *i

(P < 0.05). L.D.

represents low dose; H.D. represents high dose.
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Figure 3.18: Summary of the maximal effect of low dose and high dose Noradrenaline and Serotonin on mean
hindlimb perfusion pressure during basal (filled bars) and contraction (clear bars) protocols. Significance from preinfusion perfusion pressure represented by * (P < 0.05).

Serotonin increased perfusion pressure significantly during both basal and
contraction protocols in a similar manner (Figure 3.18). It was found that serotonin
reduces oxygen consumption in both resting and contracting skeletal muscle,
however muscle contraction diminished this effect (Figure 3.19). With higher doses of
serotonin there was a diminished effect upon both perfusion pressure and oxygen
consumption.
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Figure 3.19: Summary of the maximal effect of low dose and high dose Noradrenaline and Serotonin on
oxygen consumption during basal (filled bars) and contraction (clear bars) protocols. Significance from pre-infusion
oxygen consumption represented by * (P < 0.05).
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3.3

VASODILATORS

3.3.1 Basal Protocol
3.3.1.1

Perfusion Pressure

After the initial screening of the eight vasodilators (n = 3) to identify a
vasodilator that decreases basal oxygen consumption in similar fashion serotonin,
isoprenaline and histamine were chosen for further analysis (n = 6). Mean preinfusion hindlimb perfusion pressure was 89 ± 3mmHg (n = 6). There was a
significant dose-dependent decrease of mean hindlimb perfusion pressure after
isoprenaline infusion (Figure 3.20). Isoprenaline significantly decreased hindlimb
perfusion pressure at all doses (100nM – 100 µM) with a maximal decrease of 31 ±
2mmHg observed at the highest dose.
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Figure 3.20: The effect of Isoprenaline on mean perfusion pressure and oxygen consumption during basal (˜)
and contraction (™) protocols. Significance from pre-infusion represented by * (P < 0.05). n = 6
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Histamine infusion during basal conditions significantly decreased mean
hindlimb perfusion pressure with increasing dose (Figure 3.21). The pre -infusion
hindlimb perfusion pressure was 78 ± 3mmHg (n = 6). After infusion of 100µM
histamine, mean hindlimb perfusion pressure was significantly decreased by 7 ±
3mmHg (9%) whilst at the maximal dose of 1mM maximal decrease in perfusion
pressure of 22 ± 2mmHg (25%) was observed.
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Figure 3.21: The effect of Histamine on mean perfusion pressure and oxygen consumption during basal (˜)
and contraction (™) protocols. Significance from pre-infusion represented by * (P < 0.05). n = 6

Acetylcholine had no significant effect on mean hindlimb perfusion pressure
for doses between 100nM – 1mM that were screened (Figure 3.22). Pre -infusion
mean hindlimb perfusion pressure for animals infused with acetylcholine was 81 ±
1mmHg (n = 3). There was a dose-dependent decrease in mean hindlimb perfusion
pressure during nitroprusside administration (Figure 3.22). Resting mean hindlimb
perfusion pressure was 123 ± 1mmHg (n = 3) and was significantly decreased by
36% after 100 µM infusion and maximally by 49% after 1mM infusion. Hydralazine
had no significant effect on mean hindlimb perfusion pressure for all doses screened
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between 100nM – 1mM (Figure 3.22). Pre -infusion mean hindlimb perfusion pressure
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Figure 3.22: The effect of Acetylcholine (¢), Nitroprusside (p) and Hydralazine (q) on mean perfusion
pressure and oxygen consumption during basal protocol. Significance from pre-infusion represented by * (P < 0.05).
n=3

There was a dose-dependent decrease in mean hindlimb perfusion pressure
after bradykinin infusion (Figure 3.23). Pre-infusion hindlimb perfusion pressure was
89 ± 10mmHg for bradykinin-screened animals (n = 3). After 10µM bradykinin
infusion, mean hindlimb perfusion pressure was significantly decreased by 9%.
However, 100µM maximally decreased perfusion pressure by 15% (P = 0.05 ). There
was no significant effect observed after nifedipine administration on mean hindlimb
perfusion pressure (Figure 3.23) with a pre-infusion perfusion pressure of 108 ±
29mmHg (n = 3). Adenosine had no significant effect on mean hindlimb perfusion
pressure (Figure 3.23). Adenosine mean pre -infusion hindlimb perfusion pressure
was 105 ± 9mmHg (n = 3) which was maximally decreased after 10µM infusion by
16%. After 1mM adenosine infusion, mean hindlimb perfusion pressure was
increased by 8% (n = 3).
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Figure 3.23: The effect of Bradykinin (¢), Nifedipine (p) and Adenosine (q) on mean perfusion pressure and
oxygen consumption during basal protocol. Significance from pre-infusion represented by * (P < 0.05). n = 3

3.3.1.2

Oxygen Consumption

Isoprenaline had a positive dose-dependent relationship with hindlimb oxygen
.
consumption during the basal protocol (Figure 3.20). Mean pre-infusion Vo 2 was 0.40
± 0.10 µmol ⋅ min -1 ⋅ gww - 1 (n = 6) which was significantly increased after 100nM
infusion.
There was no significant effect on basal hindlimb oxygen consumption after
.
histamine infusion (Figure 3.21). Mean pre-infusion Vo 2 was 0.34 ±
0.06µmol ⋅ min -1 ⋅ gww - 1 (n = 6).
.
Mean pre-infusion V o2 for acetylcholine was 0.32 ± 0.11 µmol ⋅ min -1 ⋅ gww - 1 (n

= 3) and was maximally increased after 1mM acetylcholine infusion (Figure 3.22).
Nitroprusside had a positive dose-dependent response on hindlimb oxygen
.
consumption (Figure 3.22). Mean pre -infusion Vo 2 for nitroprusside was 0.22 ±
0.03µmol ⋅ min-1 ⋅ gww -1 (n = 3) which was significantly increased after 1µM (67%)
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and 10µM (78%) infusion. Hydralazine had a positive relationship with oxygen
consumption during the basal protocol (Figure 3.22). Hydralazine had a mean pre.
infusion V o2 of 0.33 ± 0.07 µmol ⋅ min-1 ⋅ gww -1 (n = 3) which was significantly
increased after 10 µM infusion.
.
Mean pre -infusion hindlimb V o2 was 0.47 ± 0.07 µmol ⋅ min -1 ⋅ gww - 1 (n = 3)
which was significantly increased after 1µM (20%) and 100µM (28%) bradykinin
.
infusion (Figure 3.23). Nifedipine significantly increased mean hindlimb Vo 2 during
.
the basal protocol (Figure 3.23). Mean pre -infusion hindlimb Vo2 was 0.38 ±
0.09µmol ⋅ min-1 ⋅ gww -1 (n = 3) which was maximally increased by 35% (P = 0.08)
.
after 100nM administration, however 1µM significantly increased Vo 2 by 27%.
.
Adenosine had a basal Vo 2 of 0.23 ± 0.04 µmol ⋅ min -1 ⋅ gww - 1 (n = 3) and 100nM
.
adenosine significantly increased Vo 2 by 75% whilst 1µM significantly increased by
69% (Figu re 3.23).

Table 3.3: Summary of the greatest effect of vasodilators screened on mean hindlimb perfusion pressure and
oxygen consumption during the basal protocol.

Drugs

n

Perfusion
Pressure
(mmHg)

.
Vo2
( µmol ⋅ min -1 ⋅ gww - 1 )

Acetylcholine

3

i 18 ± 7

h 0.19 ± 0.14

Nitroprusside

3

*i 61 ± 3

*h 0.16 ± 0.02

Hydralazine

3

i 11 ± 6

*h 0.21 ± 0.03

Bradykinin

3

i 13 ± 2

h 0.13 ± 0.06

Nifedipine

3

i 8±6

h 0.12 ± 0.04

Adenosine

3

i 17 ± 8

h 0.18 ± 0.07

Mean ± SEM. h i denotes trend, Significance from pre-infusion represented by

*h *i

(P < 0.05).

The screening of eight vasodilators with a variety of mechanism in the
autoperfused rat hindlimb resulted in the inability to identify a vasodilator that
decreases hindlimb oxygen consumption in a similar fashion to a Type B
vasoconstrictor. Table 3.3 shows the summary of the maximal effect on perfusion
pressure (Figure 3.24) and oxygen consumption (Figure 3.25) after the administration
of the six vasodilators screened.
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Figure 3.24: Summary of the maximal effect of Acetylcholine (ACh), Sodium Nitroprusside (NP), Hydralazine
(HDZ), Bradykinin (BKN), Nifedipine (NFP) and Adenosine (ADN) on mean hindlimb perfusion pressure. Significance
from pre-infusion hindlimb perfusion pressure represented by * (P < 0.05).
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Figure 3.25: Summary of the maximal effect of Acetylcholine (ACh), Sodium Nitroprusside (NP), Hydralazine
(HDZ), Bradyki nin (BKN), Nifedipine (NFP) and Adenosine (ADN) on oxygen consumption. Significance from preinfusion oxygen consumption represented by * (P < 0.05).
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3.3.2 Contraction Protocol
3.3.2.1

Perfusion Pressure

Isoprenaline and histamine were chosen from the eight vasodilators screened
to observe their effects during the contraction protocol (2 ml ⋅ min-1 flow rate). There
was a dose-dependent reduction in mean hindlimb perfusion pressure with
isoprenaline administration (Figure 3.20). Mean pre -infusion perfusion pressure was
180 ± 9mmHg (n = 6). During the contraction protocol, isoprenaline infusion
significantly decreased mean hindlimb perfusion pressure after the infusion of 1 µM to
100µM.
Histamine infusion during the contraction protocol resulted in a dose dependent reduction in mean hindlimb perfusion pressure for all doses (Figure 3.21).
Pre-infusion perfusion pressure was 182 ± 4mmHg (n = 6). 10µM histamine
administration resulted in a reduction of perfusion pressure by 5% whilst 100µM
infusion maximally reduced perfusion pressure by 9%.

3.3.2.2

Oxygen Consumption

Isoprenaline infusion resulted in a significant dose-dependent increase in
.
.
hindlimb Vo 2 during the contraction protocol (Figure 3.20). Mean Vo2 prior to
isoprenaline infusion was 0.39 ± 0.08 µmol ⋅ min -1 ⋅ gww - 1 (n = 6) which was maximally
increased by 0.59 ± 0.13 µmol ⋅ min -1 ⋅ gww - 1 after 100µM isoprenaline infusion.

Histamine administration significantly increased mean hindlimb oxygen
consumption during the contraction protocol in a dose -dependent manner (Figure
.
3.21). Mean pre -infusion Vo 2 was 0.43 ± 0.06 µmol ⋅ min -1 ⋅ gww - 1 (n = 6) where
.
100µM histamine infusion resulted in a maximal increase in hindlimb Vo 2.
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3.3.2.3

Force of Contraction

There was no significant effect on either +dT/dtmax or –dT/dt after isoprenaline
infusion (Figure 3.26). Mean pre -infusion +dT/dtmax was 9.46 ± 0.57 N ⋅ s-1 and
-dT/dtmax was -7.38 ± 0.52 N ⋅ s -1 (n = 6).
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Figure 3.26: The effect of Isoprenaline on maximal rate of contraction (¢) and relaxation (£) during muscle
contraction. The dashed line indicates pre-infusion maximal rate of contraction and relaxation. Significance from preinfusion represented by * (P < 0.05). n = 6

Histamine infusion had no significant effect on the +dT/dtmax but did
significantly increase -dT/dtmax for all doses except for 10nM (Figure 3.27). Mean preinfusion +dT/dtmax was 11.42 ± 0.67N ⋅ s -1 whilst -dT/dtmax was -9.75 ± 0.69 N ⋅ s -1 (n =
6). 10nM histamine maximally increased +dT/dtmax to 14.52 ± 1.70 N ⋅ s-1 and
decreased -dT/dtmax to -15.32 ± 1.31 N ⋅ s-1 (n = 6, P = 0.056). After 100nM infusion ,
-dT/dtmax was significantly decreased to -14.99 ± 2.32 N ⋅ s-1.
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Figure 3.27: The effect of Histamine infusion on maximal rate of contraction (¢) and relaxation (£) during
muscle contraction. The dashed line indicates pre-infusion maximal rate of contraction and relaxation. Significance
from pre-infusion represented by * (P < 0.05). n = 6

Isoprenaline and histamine significantly decreased mean hindlimb perfusion
pressure during both basal and contraction protocols (Figure 3.28). Both vasodilators
increased mean hindlimb oxygen consumption during both protocols however the
greatest effects were observed during the contraction protocol (Figure 3.29).

Table 3.4: Summary of the greatest effect of Isoprenaline and Histamine on mean hindlimb perfusion pressure
and oxygen consumption during basal and contraction protocols.

Drugs

Protocol

n

Perfusion
Pressure
(mmHg)

.
Vo 2
( µmol ⋅ min -1 ⋅ gww - 1 )
*h 0.19 ± 0.06

Isoprenaline

Basal

6

*i 31 ± 2

Histamine

Basal

6

*i 22 ± 2

h 0.19 ± 0.09

Isoprenaline

Contraction

6

*i 42 ± 7

*h 0.59 ± 0.13

Histamine

Contraction

6

*i 18 ± 5

*h 0.35 ± 0.13

Mean ± SEM. h i denotes trend, Significance from pre-infusion represented by

*h *i

(P < 0.05).
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Figure 3.28: Summary of the maximal effect of Isoprenaline and Histamine on mean hindlimb perfusion
pressure during basal (filled bars) and contraction (clear bars) protocols. Significance from pre-infusion hindlimb
perfusion pressure represented by * (P < 0.05).
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Figure 3.29: Summary of the maximal effect of Isoprenaline and Histamine on oxygen consumption during
basal (filled bars) and contraction (clear bars) protocol. Significance from pre-infusion oxygen consumption
represented by * (P < 0.05).

70

4

CHAPTER FOUR

Discussion and Conclusions
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4.1

DISCUSSION

Summary
The aim of this thesis was to investigate the existence of dual vascular
pathways within the skeletal muscle of a physiologically relevant model. This
hypothesis has been primarily studied in the isolated perfused rat hindlimb during
exogenous vasoconstrictor administration. The results from this thesis support the
Clark classification of vasoconstrictors (Clark et al. 1995) in resting muscle in regards
to Type B vasoconstrictors only. However, the effect of the Type B vasoconstrictor on
oxygen consumption is diminished during times of increased metabolic demand
(such as exercise). This could be due to local metabolite-mediated vasodilation. No
significant effect on oxygen consumption was observed with adequate oxygen
delivery to match basal metabolic rate after increased oxygen availability by
increased nutritive flow after histamine, isoprenaline or noradrenaline infusion. During
muscle contraction, vasodilator infusion significantly increased oxygen consumption
possibly because of the direct effect of the agonist on the muscle or increased
nutritive flow resulting in increased oxygen availability. The inability to identify an
exogenously administered vasodilator that selectively vasodilates the non -nutritive
bed suggests that the locale that a vasodilator is released from, rather than variations
in receptor location, determines skeletal muscle blood flow redistribution.

Autoperfused Hindlimb
The autoperfused rat hindlimb model maintained physiological resting
vascular tone, and hence the capacity to respond to either exogenous
vasoconstrictors or vasodilators. Blood parameters were maintained at physiological
levels throughout the experiments as discussed above (see blood profiles). This
ability to provide high oxygen delivery ensured that the vasoconstrictor / vasodilator
responses could be evaluated during the high demand conditions associated with
repetitive muscle contraction. This was an improvement on previous models and
provided conditions for physiological effects such as changes in shear stress, pH,
CO 2 transport, haematocrit and haemoglobin saturation in which to occur.
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Resting hindlimb perfusion pressure is very similar to systemic blood pressure
˜ 90mmHg at 1 ml ⋅ min-1 flow rate in contrast to the perfusion pressure of ˜ 20mmHg
observed at a flow rate of 2 ml ⋅ min-1 in the isolated perfused hindlimb (Figure 4.1)
(Colquhoun et al. 1988; Ye et al. 1990). Resting vascular tone, capable of increases
or decreases, is present in the autoperfused hindlimb but not in the isolated perfused
hindlimb. Hence, to obtain a perfusion pressure in the vicinity of in vivo systemic
blood pressure in the isolated perfused hindlimb, a flow rate in excess of 20

ml ⋅ min -1 is required, which is much greater than that observed in vivo . Janiak et al.
(2002) reported that at rest, in vivo iliac arterial blood flow is ˜ 1.5 ml ⋅ min -1 . There
was no effect on systemic blood pressure whilst hindlimb perfusion pressure
increased to ˜ 160mmHg at 2 ml ⋅ min-1 in the autop erfused hindlimb. The increase in
flow rate during the contraction protocol was aimed to mimic the increase in cardiac
output observed during exercise. However since there is no generalised increase in
systemic sympathetic activity to act on the heart and vasoconstrict low metabolic
demand tissue (such as the digestive organs during sciatic nerve stimulation) there
was no change in systemic blood pressure, unlike in exercise.
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Figure 4.1: The effect of flow rate on oxygen consumption and perfusion pressure in the isolated perfused
hindlimb (adapted from Ye et al. (1990)) (˜) and the autoperfused hindlimb (data from this study) (™).
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The use of the animal’s own blood and lungs facilitates the delivery of
physiological oxygen supply (O2 bound to Hb not saturated buffer) to both resting and
contracting muscle. Inability to provide physiological delivery of oxygen to the muscle
is a major limitation of both in vitro and in situ studies (Bonen et al. 1994). Oxygen
consumption at rest in the autoperfused hindlimb is 4-fold greater than in the isolated
buffer-perfused hindlimb. Only 3% of oxygen transported within the blood in vivo is
dissolved, with the remainder carried in the erythrocyte. Even with an arterial Po 2
greater than 400mmHg (compared with in vivo arterial Po 2 ˜ 100mmHg), metabolic
demand is not matched by availability unless delivered at very high flow rates.
Further, because cell-free perfusate oxygen content is not sufficient to match
metabolic rate the muscle cells will be hypoxic even at rest at in vivo flow rates.
Oxygen consumption in the autoperfused rat hindlimb at rest is within the normal in
vivo range of 0.3 to 0.4 µmol ⋅ min-1 ⋅ gww -1 (Côté et al. 1985).
Hindlimb oxygen consumption decreased when flow rate was increased to
2 ml ⋅ min-1 with the muscle at rest then increased to above low flow resting values
during repetitive muscle contraction. It has been clearly shown in the pulmonary
system that a significant increase in cardiac output (increased flow rate) decreases
erythrocyte transit time therefore affecting erythrocyte loading and unloading of
oxygen and oxygen diffusion into the cell (Powers and Williams 1987). In this study,
when the hindlimb flow rate was increased, it is assumed that erythrocyte transit time
would be decreased and it is likely that unloading of oxygen would be limited in the
capillary bed of the muscle. Furthermore, blood flow is distributed unevenly
throughout the capillary bed (flow heterogeneity) at rest (Vetterlein et al. 1977;
McDonagh et al. 1982; Lindbom and Arfors 1985; Piiper et al. 1985; Duling and
Damon 1987). One-third to one-half of all capillaries are perfused at any time, with a
homogeneous spatial distribution. The average erythrocyte velocity is less than 20%
of the average maximal velocity obtained during maximal exercise (Lindbom 1983).
Capillary recruitment during the transition from rest to exercise occurs within the first
15 seconds beginning in areas where capillary perfusion density is lowest. Mean
capillary perfusion increa ses by 1.5- to 3-fold and flow increases 7-fold, which leads
to a drop off in erythrocyte transit time by one -third (Honig et al. 1980). Further, at
rest there are no other stimuli, such as changes in muscle temperature, pH, CO 2 or
demand of O 2, to enhance this unloading, which is known as the Bohr effect (Rowell
and Shepard 1996). T here are also vascular limitations to oxygen exchange within
the skeletal muscle. These include oxygen consumption to blood flow inequity;
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limitation of diffusive transport of oxygen from the muscle microcirculation to the
mitochondria; shunting of blood flow through the non-nutritive route; and diminished
total flow (Wagner 2003).
Another possible influence on oxygen consumption at high flow rates would
be blood flow redistribution into the low resistance non-nutritive vessels, which have
lower metabolic demand therefore resulting in reduced oxygen consumption. It is
likely that there is a combination of both reduced erythrocyte transit time and
increase in blood flow into the low resistant non -nutritive pathway, which would
explain the decrease in oxygen consumption with an increased flow rate. Therefore
an increase in oxygen consumption with increase in flow rate at rest (as seen in
buffer perfused isolated hindlimbs) most likely reflects increased delivery to meet
previously unmet oxygen demand.
The effect of the infused saline vehicle upon both hindlimb perfusion pressure
and oxygen consumption could be a result of a short-term change in viscosity and/or
temperature of the perfusate. Saline was held at room temperature before infusion.
To accommodate this saline effect, all measures of drug effects on perfusion
pressure and oxygen consumption were made after the effects of the saline vehicle
had subsided.
The stimulated twitch protocol was used to increase metabolic demand of the
perfused hindlimb. This particular protocol was selected to reduce the chance of
rapid fatigue . As a result the twitch tension produced was lower than many other
studies. Mean twitch tension in this thesis was 0.235 ± 0.020N (24 ± 2g, n = 8) whilst
Shiota and Sugano (1986) reported a mean twitch tension of 0.422 ± 0.049N (43 ±
5g, n = 4) in the isolated perfused rat hindlimb both at 5Hz. Shiota and Sugano
(1986) used rats with a weight range of 180 -230g compared with 450-785g used in
this study. Therefore it can be speculated that maximal muscle contraction or tetanic
stimuli would further ni crease hindlimb oxygen consumption with matched oxygen
delivery above those reported here.

Effects of Serotonin on Oxygen Consumption and Perfusion Pressure
Serotonin significantly decreased hindlimb oxygen consumption at rest during
vasoconstriction

of

the

hindlimb

vasculature,

confirming

the

selective

vasoconstriction observed by Clark et al. (1995). Changes in perfusion pressure were
closely associated with changes in oxygen consumption at rest and during muscle
contraction (Figure 3.13). The magnitude of the serotonin decrease in oxygen
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consumption was however diminished during the high oxygen demand conditions of
repetitive contraction which may be due to the local release of vasodilator
metabolites to match oxygen delivery to oxygen demand.

Serotonin decreases oxygen uptake, free fatty acid efflux and lactate
production which can be blocked by 5-HT 2-antagonist infusion (Dora et al. 1991;
Clerk et al. 2003). Insulin-mediated glucose uptake is also inhibited especially in
muscles rich in fast-twitch glycolytic fibres (Rattigan et al. 1993; Baron and Clark
1997). This decrease in hindlimb metabolism by Type B vasoconstrictors is thought
to occur through selective vasoconstriction of the nutritive blood flow redirecting flow
into the non-nutritive bed (Figure 4.2). It is proposed that this occurs at the terminal
arteriole, proximal to the muscle tissue and distal to the connective tissue, increasing
perfusion of the associated connective tissue capillary beds and decreasing oxygen
uptake. However, further studies to identify the precise location of 5-HT 2 receptors
within the microvasculature are necessary to link the vasculature and metabolic
changes occurring during serotonin infusion.
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Figure 4.2: A simplified schematic of the structure of the vasculature of skeletal muscle adapted from
Borgström et al. (1988). TE represents Terminal Arteriole; TR: Transverse Arteriole; CAP: Capillary Bed.

At higher doses, the serotonin -mediated increases in perfusion pressure were
diminished . This phenomenon has been reported in previous studies (Haddy et al.
1959; McCubbin et al. 1962; Emerson et al. 1973; McLennan and Taylor 1984;
Blackshear et al. 1985). The diminished increase could be due to simultaneous
vasodilation and vasoconstriction at differing sections of the vasculature by different
subtypes of the 5-HT receptors. Serotonin has a direct vasodilator effect when the
initial resistance is high, which can be unmasked during 5-HT 2 blockade (McLennan
and Taylor 1984). Serotonin-mediated vasodilation has also been reported to involve
the inhibition of release noradrenaline during sympathetic stimulation (Haddy et al.
1959; McCubbin et al. 1962; Emerson et al. 1973; Blackshear et al. 1985). However
in this study, the serotonin-mediated increase in basal perfusion pressure was
diminished whilst resting tone was maintained, therefore the possibility of two
serotonin receptors in the microvasculature is most likely to explain this
phenomenon ; one that vasoconstricts (5-HT 2) and another that vasodilates (5 -HT 1).
The vasodilator phenomenon is unmasked when the vasoconstrictor receptors are
saturated or blocked (Haddy et al. 1957; McLennan and Taylor 1984).
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Dora et al. (1994) reported that muscle aerobic contractility is inhibited during
serotonin infusion due to diminished nutrient delivery through redirection of blood
flow by selective vasoconstriction. The vasoconstrictor action of serotonin was not
overcome by local vasoactive metabolites released during skeletal muscle
contraction. In contrast, serotonin had no significant effect on the maximal rate of
muscle contraction or relaxation in this study. The effect of serotonin on hindlimb
oxygen consumption was diminished during the contraction protocol although if
nutritive flow was reduced it would be expected that the twitch characteristic would
differ due to reduced oxygen availability. Despite this, the reduced nutritive flow might
still provide sufficient oxygen for the twitch contractions in the presence of high
oxygen content. The differing results could lie with the fact that Dora et al used a
tetanic protocol whilst this study used a twitch protocol.

Noradrenaline and the α-Adrenoceptor
Noradrenaline significantly increased hindlimb perfusion pressure in the
autoperfused hindlimb , which supports previous findings (Powell and Skinner 1968;
Shiota and Masumi 1988; Ye et al. 1990). However, the metabolic effects of
noradrenaline administration in the autoperfused hindlimb do not equate with those
reported by the Clark group in which noradrenaline infusion increased both perfusion
pressure and hindlimb oxygen consumption at physiological doses (< 1µM) (Clark et
al. 1995). Higher dose noradrenaline (> 1µM) decreases hindlimb oxygen
consumption and inhibits insulin -mediated glucose uptake via α-adrenoceptor
activation in the perfused hindlimb, but not in isolated muscle preparations. It is
thought that high dose noradrenaline-induced vasoconstriction occurs in large
arterioles downstream from branching points for shunting of blood into the venous
circulation (Rattigan et al. 1995). The difference may lie in the experimental
conditions.
Noradrenaline-induced metabolic changes are thought to occur by selective
vasoconstriction of the non -nutritive route to redistribute skeletal muscle blood flow.
This occurs at the transverse arteriole, distal to the muscle tissue and proximal to the
connective tissue, therefore increasing perfusion of the muscle capillary beds via αadrenoceptor activity to increase oxygen uptake (Figure 4.2) (Côté et al. 1985;
Newman et al. 1997). This increase in oxygen consumption has been reported by a
variety of groups (Powell and Skinner 1968; Grubb and Folk 1977; Clark et al. 1994;
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Ye et al. 1995) and it can be totally blocked by α -adrenoceptor blockade, but not by
β-adrenoceptor blockade (Grubb and Folk 1977).
The inability to observe noradrenaline-induced increases in oxygen
consumption during vasoconstriction in the autoperfused hindlimb has been reported
previously (Gronert et al. 1980; van-Hardeveld et al. 1980; Shiota and Masumi 1988;
Gainer et al. 1993). van-Hardeveld et al. (1980) reported that the oxygen
consumption was significantly higher and the increase in perfusion pressure following
noradrenaline infusion was significantly blunted in cold acclimated rats compared to
control animals. Similarly, in a study carried out in cold acclimated animals by Shiota
and Masumi (1988) found that hindlimb oxygen consumption was significantly
increased with no change in lactate release, however they found that the increase in
perfusion pressure was identical to the control animals. These studies support the
evidence provided in this thesis and the theory that changes in oxygen consumption
by noradrenaline can occur independently of the changes to vascular resistance.
Skeletal muscle arterioles appear to have both α- and β-adrenoceptors, and
activation of them influences erythrocyte velocity through the capillary (α decreases,
β increases) (Yu and Tyml 1997). It is thought that the occupation of α 2adrenoceptors does not stimulate the effector system but inhibits α 1-adrenoceptor
activity in a competitive manner (Kobinger and Pichler 1981). The α 1-adrenoceptor is
the most prolific α -adrenoceptor in the peripheral vasculature although many studies
have shown that the α 2-adrenoceptor is found not only on the presynaptic membrane
of adrenergic nerves but also on the postsynaptic membrane to mediate the
constriction of vascular smooth muscle (Docherty et al. 1979; Timmermans et al.
1979; Timmermans and van-Zwieten 1981; Alabaster and Davey 1984; Ruffolo 1984;
Chotani et al. 2004). Large arteriole smooth muscle cells and venules contain both
α 1- and α 2-adrenoceptors. Whilst early reports suggested that precapillary arterioles
such as the transverse and terminal arterioles contain predominantly α 1adrenoceptors (Faber 1988), more recent studies have concluded that precapillary
vessels predominantly contain α 2-adrenoceptors (Yu and Tyml 1997; Xu et al. 1998).
The distribution of α 2-adrenoceptors in the small, precapillary arterioles could be
involved in prominent or unique regulatory features evident at this level of the
microcirculation such as vasomotion. Differences in excitation-contraction coupling of
vascular smooth muscle cells could also be due to the dominant subtype of αadrenoceptors at the various levels of the vasculature (Faber 1988).
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Nitric oxide is thought to play a key role in functional sympatholysis, where
systemic sympathetic vasoconstriction is negated by local metabolic vasodilation
(physiological antagonism) (Segal and Kurjiaka 1995; Hansen et al. 1996). It is
thought that this could be a mechanism to tightly regulate blood flow and oxygen
delive ry to skeletal muscle with the reflex control of the precapillary resistance
arterioles (Anderson and Faber 1991; Buckwalter et al. 2001). In the human forearm,
α-adrenoceptor-mediated vasoconstriction remains intact during infusion of
nitroprusside (Rosenmeier et al. 2003). This is in contrast to animal studies where α 2but not α 1-adrenoceptor sensitivity is diminished during nitric oxide infusion (Thomas
and Victor 1997). During exercise, α-adrenoceptor-mediated vasoconstriction is
diminished at various levels of the vasculature (Buckwalter et al. 2001) whilst glucose
production is markedly increased during intense exercise via α-adrenoceptor
stimulation (Sigal et al. 1994). Vasoactive metabolite-mediated vasodilation
overcomes the α 2-mediated vasoconstriction of precapillary arterioles with no effect
seen on the large arterioles during light exercise. During intense exercise, α 1mediated vasoconstriction of the large arterioles can be overcome by the release of
vasoactive metabolites (Anderson and Faber 1991; Buckwalter and Clifford 1999;
Buckwalter et al. 2001). Therefore the effect of exogenous activation of skeletal
muscle α-adrenoceptors during exercise would be dependent upon the intensity of
exercise. The diminished sensitivity of the α-adrenoceptors during exercise suggest
that the α-adrenoceptors may not selectively vasoconstrict the non -nutritive pathway,
although it may play a role during basal conditions.

Selective vasoconstriction within skeletal muscle may play a crucial role in
nutrient and hormone delivery and nutrient retention during basal conditions. The
differing location of α-adrenoceptor subtypes within the microvasculature could play a
crucial role in blood flow regulation. However, the use of the non -selective αadrenoceptor agonist noradrenaline did not reveal the differing effects of the αadrenoceptor subtypes upon basal blood distribution and skeletal mu scle
metabolism. Therefore an α 2-adrenoceptor agonist may be used to selectively
vasoconstrict the precapillary arterioles of skeletal muscle to redistribute blood flow if
the α 2-adrenoceptor is the most dominant subtype within the transverse and terminal
arterioles. Nevertheless, endogenous control via the adrenergic nervous system
must be mediated by the concentration of endogenous transmitters noradrenaline

80

and adrenaline, the location of their release and the location of the receptor
subtypes.

Mechanisms for Communication of Metabolic Demand
If the effect of serotonin on oxygen consumption is achieved by selective
vasoconstriction of the nutritive pathway associated with the muscle fibres, the
reduced effect on oxygen consumption during the contraction protocol may be due to
the local effects of the twitch (such as the release of vasoactive metabolites) to
increase local oxygen supply, hence overriding the exogenous vasoconstriction of
the nutritive pathway (physiological antagonism). In a review of va soactive
metabolites released from skeletal muscle cells Altura (1971) reported that they all
vasodilate arterioles (Table 1.1). It is known that systemic sympathetic
vasoconstriction is negated by local metabolic vasodilation (functional sympatholysis)
(Anderson and Faber 1991; Buckwalter and Clifford 1999; Buckwalter et al. 2001).
The communication of metabolic demand from the tissue to the sites of regulation,
the transverse and terminal arterioles, has been intensively investigated. The site for
regulating blood flow at metabolically active muscle must be upstream from the
active cells and the main mechanism for increased blood flow appears to be by
vasodilatory agents.
The mechanism for upstream communication has yet to be defined however
there is no adrenergic innervation within capillaries of mammalian skeletal muscle
(Dietrich and Tyml 1992b). It has been hypothesised that upstream communication
via cell-to-cell coupling, erythrocytes as a sensor, or diffusion of a signal from the
venule endothelium could be possible mechanisms for metabolites released by
skeletal muscle cells to selectively influence blood flow to those cells. The following
factors have been implicated in the communication of metabolic demand to increase
supply.

Endothelial-Derived Compounds
The endothelium of capillaries and arterioles release a variety of compounds
under different conditions that can regulate arteriolar resistance. The removal of
vascular endothelium abolishes any flow-induced vasodilation in situ and in vitro
(Pohl et al. 1986; Rubanyi et al. 1986). Arteriolar diameter is controlled by a variety of
mechanism including endothelial-derived relaxing factors (EDRF), endothelialderived hyperpolarising factors (EDHF) and endothelial-derived nitric oxide (EDNO).
Rubanyi et al. (1986) demonstrated that both an increase in flow and the introduction
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of pulsatile flow augments the production of prostacyclin and another EDRF’s in the
dog femoral artery. Bradykinin, prostacyclin, cyclic AMP, adenosine, 5’-AMP and
cyclic GMP have been ruled out as possible EDRF s (Furchgott and Zawadzki 1980).
Arachidonic acid products, epoxygenase products, potassium or endogenous
cannabinoids have been suggested as possible EDHF s (Triggle and Ding 2002).
EDHF activation of Ca 2+-dependent K+ channels at the local site is required to illicit a
conducted vasodilation in the hamster cremaster muscle , but nitric oxide and
prostaglandins play a less important role in initiating a conducted vasodilation (Hoepfl
et al. 2002). Potassium ions pass from the intra- to the extracellular space during
muscle activity (Kjellmer 1965), and low concentrations of exogenous potassium
dilate arteries and arterioles, whilst high concentrations constrict large arteries (>
0.5mm) that lie external of the active muscle (Dawes 1941). Physiological
concentrations of exogenous potassium produces a vascular response similar to the
vascular responses observed during exercise (Kjellmer 1965).
Acetylcholine -induced vasodilation was initially thought to be mediated
through the release of an unknown EDRF (Furchgott and Zawadzki 1980; Moncada
et al. 1991) and EDNO (Hester et al. 1993). Acetylcholine activates calciumcalmodulin-dependent nitric oxide synthase, which uses L-arginine as a substrate.
Inhibition of EDNO-release significantly decreases vasodilation of first- and secondorder arterioles during hype raemia , but has no effect on third-order arterioles.
However, by using L-arginine, the authors may have bypassed other receptor-linked
effects of acetylcholine and directly caused an increase in nitric oxide (Frame and
Sarelius 1995). The relationship between acetylcholine and nitric oxide is a good
example and exemplifies the complex nature of the regulation of skeletal muscle
blood flow.

Conducted Vasomotion
Conducted vasomotion describes the effect that the introduction of an agent
(be it pharmacological or metabolic) at the local site (capillary) has on the remote
site’s (arteriole) vasculature resistance. This could explain the vasculature changes
as a possible mechanism for upstream communication of metabolic demand. A
variety of agonists have been shown to induce a conducted vasomotion in a variety
of preparations (Table 4.1). During local administration of acetylcholine and
noradrenaline to skeletal muscle capillaries, propagation of the local vasomotor
response upstream to a remote site has been reported, where acetylcholine
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increased, whilst noradrenaline decreased erythrocyte velocity. However, during
post-propagation muscarinic, or α-adrenoceptor blockade the effects of acetylcholine
and noradrenaline were not blocked (Segal and Duling 1989; Kurjiaka and Segal
1995).

Table 4.1: Adapted from Gustafsson and Holstein-Rathlou (1999). Summary of local and conducted vasomotor
responses in arterioles in a variety of models to various vasoactive agents applied extraluminally.

Local
Response

Conducted
Response

VD

VD

Hamster Cheek Pouch

VD

VD

Hamster Striated Muscle

VD

VD

Mouse Striated Muscle

Methacholine

VD

VD

Hamster Cheek Pouch

Adenosine

VD

Variable

Hamster Cheek Pouch

Bradykinin

VD

Variable

Hamster Cheek Pouch

Nitroprusside

VD

NR

Hamster Cheek Pouch

VD

NR

Hamster Striated Muscle

VC

VC

Hamster Cheek Pouch

VC

VC

Rat Mesentery

Adrenaline

VC

VC

Rat Mesentery

Phenylephrine

VC

VC

Hamster Cheek Pouch

KCl

VC

VC

Hamster Cheek Pouch

Vasopressin

VC

NR

Hamster Cheek Pouch

ATP

VC

VC

Hamster Striated Muscle

L-Arginine

NR

VD

Hamster Striated Muscle

Agonist
Acetylcholine

Noradrenaline

Vasculature

VD: Vasodilation; VC: Vasoconstriction; NR: No response.

Blockade of α 2-adrenoceptors abolished the noradrenaline-induced increase
in erythrocyte velocity (Dietrich and Tyml 1992a). Noradrenaline application induces
smooth muscle cell depolarisation, which is conducted between smooth muscle cells
to induce contraction of adjacent cells and the depolarisation is conducted
independently of endothelial cells. Acetylcholine acts on muscarinic receptors
(Furchgott 1983) to induce a local and conducted hyperpolarisation along the
arteriole between both smooth muscle and endothelial cell layers, which decay with
distance up to 600µm (Figure 4.3) (Segal and Duling 1989; Song and Tyml 1993;
Welsh and Segal 1998). Dual application of noradrenaline on two capillaries
produced a greater decrease in erythrocyte velocity than a single application,
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whereas dual application of noradrenaline and acetylcholine attenuated the
acetylcholine response (Song and Tyml 1993).

-Cystine application in the

L

microcirculation also initiates remote vasoconstriction whilst L-arginine induces a
remote vasodilation ≥ 1000µm upstream similar to acetylcholine. Remote
vasodilation by these agonists was found to have a rapid onset that cannot be
explained by simple diffusion (Frame 1999).
Smooth muscle cells and endothelial cells are electrically coupled via gap
junction proteins both homocellularly and heterocellularly in the microvasculature
(Little et al. 1995; Xia et al. 1995). The molecule involved in signal transmission
between vascular smooth muscle and the endothelium is unknown but it has been
postulated that the increase in intracellular calcium generates a diffusion gradient
that drives calcium through myoendothelial cell junctions and into the endothelial
cells, which stimulate nitric oxide synthesis (Dora et al. 1997). The conducted
vasomotion induced by L-arginine, noradrenaline and acetylcholine can be inhibited
by non-specific gap junction inhibitors (Frame 1999).

Figure 4.3: An example of the relationship between the local and remote site during micropipette application of
the agonist at the local site of the capillary adapted from Frame (2000).

After intraluminal application of adenosine triphosphate (ATP) into skeletal
muscle venules, an 8% increase in arteriolar diameter was recorded up to 450µm
upstream, which resulted in a 63% increase in secondary arteriolar and 50%
increase in terminal arteriolar erythrocyte flux (Collins et al. 1998). Intra-arteriole
infusion of ATP caused a similar increase in arteriolar diameter that, according to
Poiseuille’s law, would lead to a 17% increase in flow (McCullough et al. 1997).
Systemic administration of L-NAME (nitric oxide synthase inhibitor) prior to venous
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ATP application eliminated any conducted responses and this effect was reversed by
-arginine systemic application, which suggests that nitric oxide plays a role in the

L

conducted response of ATP (Collins et al. 1998). Adenosine is able to generate
remote upstream arteriolar vasodilation which can not be explained by direct
arteriolar stimulation, capillary stimulation along the same flow path, diffusion to the
remote arteriole, increases in blood flow or veno-arteriolar transfer (Rivers and
Frame 1999). It has therefore been speculated that changes in membrane potential
could be a means for capillaries to communicate upstream to arterioles to optimise
blood flow and oxygen delivery to downstream tissue (McGahren et a l. 1998).
Muscle contraction not only cause s local arteriolar dilation but also initiates
conducted vasodilation upstream. The conducted vasodilation signal differs from the
capillary level signal and from pharmacologically induced signal via acetylcholine
directly at the arteriolar level (Murrant and Sarelius 2000b). It does not involve
perivascular nerves or gap junctions, and it has been proposed by Murrant and
Sarelius (2000b) that local paracrine signalling would account for transmission of the
conducted vasodilation along the vessel wall. Although remote responses to some
agonists are induced by primary signals to locally dilate, additionally, network
changes in flow can stimulate extensive remote changes in diameter via separate or
secondary mechanisms (Frame 2000). Skeletal muscle fibre capillaries can sense
muscle contraction and initiate KATP channel, adenosine , and nitric oxide dependent
remote arteriolar vasodilation (Cohen and Sarelius 2002). Local vasodilation is KATP
channel, adenosine, and nitric oxide dependent whilst upstream dilation is KATP
channel, and adenosine , but not nitric oxide dependent whereas the conducted
signal is independent of these components (Murrant and Sarelius 2002). The
evidence reported supports the contention that the conduction of electrical signals
upstream via gap junctions to the regulatory sites of vascular control is one possible
mechanism to tightly regulate muscle metabolism to blood flow.

Erythrocyte
One group of researchers have focused on the erythrocyte as an oxygen
sensor (Figure 4.4). ATP is released from the erythrocyte in response to hypoxia,
hypercapnia , and low pH; conditions associated with decreased oxygen supply
relative to demand (Ellsworth et al. 1995; McCullough et al. 1997). Extraluminal
application of ATP induces a dose -dependent conducted vasoconstriction whilst, as
reported above, intraluminal application induces a conducted vasodilation
(McCullough et al. 1997). ATP is known to bind to the purine P 2y receptors that are
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located on the luminal surface of peripheral vascular endothelium. The binding of
ATP to these receptors induce s the production of nitric oxide and prostacyclin I2
(PGI2) both of which are potent vasodilators of the peripheral vasculature (Ellsworth
et al. 1995). The erythrocyte can also release nitric oxide as oxygen saturation is
decreased during increased metabolic demand. The nitric oxide is bound to form Snitrosohaemoglobin and is released, via allosteric transition, to induce vasodilation
(Secomb and Pries 2002). Haemoglobin can also contract the vasculature by
decreasing the steady state levels of free nitric oxide, resulting in increased blood
pressure (Jia et al. 1996). The erythrocyte can act by two mechanisms to regulate
arteriolar resistance. Therefore, it has been proposed that if the erythrocyte does act
as an oxygen sensor via the release of ATP, it would eliminate the need for a diverse
network of sensing sites throughout the microvasculature , and provide an efficient
means for precisely matching supply with demand (Ellsworth 2000).

Figure 4.4: Taken from Ellsworth (2000) showing the hypothesis for erythrocyte derived ATP regulation of
skeletal muscle blood flow. NO represents Nitric Oxide; EDHF represents Endothelial Derived Hyperpolarising
Factor; SMC represents Smooth Muscle Cells; Endo represents Endothelial Cells; P2y and P2u represent subtypes of
purine receptors

Venule Endothelium
A role for venules as a site of arteriolar diameter regulation has also been
proposed since small arterioles and venules are paired within many branching levels
of the microvasculature. It is thought that vasoactive metabolites released during
times of increased metabolic demand could diffuse from the venule to the paired
arteriole (Holtz et al. 1983; Hester and Choi 2002). Shear stressing of venular
endothelium during rest releases nitric oxide, resulting in vasodilation of the
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associated arteriole but this mechanism does not play a part during muscle
contraction (Boegehold 1996). Venular endothelium is able to release multiple
endothelium-derived relaxing factors in response to acetylcholine application onto the
venular wall thus dilating the adjacent arteriole (Falcone and Bohlen 1990).
Venular endothelium can release PGI2, which is a cyclooygenase product that
can diffuse from the venule to the paired arteriole. When the venule is treated with a
cyclooygenase inhibitor the paired arteriole does not dilate, unlike the unpaired
arterioles (Hester and Choi 2002). The mechanism by which metabolic
communication occurs in unpaired vasculature is unknown. The uptake of vasoactive
metabolites (such as adenosine) by the venules can lead to vasodilation of the paired
arteriole through diffusion of the metabolite from venule to arteriole (Hester 1990,
1993). When the venular endothelium is removed, arteriolar vasodilation is
diminished in response to muscle contraction but the underlying mechanism is still
unclear (Saito et al. 1994). Figure 4.5 combines the erythrocyte and venule
endothelium as a possible mechanism that could regulate metabolic demand at a
local level within the microvasculature.

Figure 4.5: Taken from Hester and Choi (2002). The proposed regulation of blood flow during exercise or rest.
The change in the venous blood such as hypoxia, hypercapnea, and acidosis stimulate erythrocytes (RBC) to release
adenosine triphosphate (ATP). ATP stimulates prostanoid release from the venular endothelium to vasodilate the
adjacent terminal and/or transverse arteriole.
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The evidence presented by this study and others (Dora et al. 1991; Dora et al.
1992; Dora et al. 1994; Clark et al. 1995; Newman et al. 1996) show that the
metabolic effects of serotonin in resting and contracting muscle appear to be
mediated via vascular redistribution of total flow into the non-nutritive pathway.
However in contracting muscle, local metabolic vasodilation acts as a physiological
antagonist to overcome the selective vasoconstriction of the nutritive bed, not only by
serotonin but also sympathetic activation (functional sympatholysis). The ability of
serotonin to significantly reduce nutritive blood flow may be crucial to retain nutrients
during haemorrhage and/or platelet aggregation.
With the rationale that local metabolic-mediated changes in blood distribution
are achieved via vasodilation, the identification of selective vasodilation in a model
with resting tone could supply further evidence of a dual vascular pathway. Studies
using the isolated perfused hindlimb were unable to study vasodilators without prior
infusion of a vasoconstrictor to establish resting vascular tone. Selective vasodilation
would arise according to the location of the receptors within the microvasculature, as
is the case with the vasoconstrictors (Figure 4.2).

Basal Nutritive Blood Flow and Oxygen Supply
It would be expected that if selective vasoconstriction, or non-selective
vasodilation increases the number of perfused capillaries to increase nutritive blood
flow, this would result in an increase in basal skeletal muscle oxygen consumption,
however this was not the case. At rest there was no significant effect of isoprenaline,
histamine or low dose noradrenaline on oxygen consumption. With an increase of
oxygen availability via vascular redistribution no change in basal metabolic rates was
observed in the presence of high oxygen delivery in this study. Significant changes in
perfusion pressure were observed at rest. This raises the question: does oxygen
delivery dictate uptake?
Isoprenaline was chosen for further study as a vasodilator that decreases
hindlimb perfusion pressure whilst increasing oxygen consumption. Histamine was
chosen to study further because during two of the three screening trials an initial
decrease in hindlimb oxygen consumption was observed followed by an increase.
However this initial decrease was only observed in two of the six animals studied at
rest. It was not observed during the contraction protocol.
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Infusion of isoprenaline significantly decreased perfusion pressure during the
basal protocol (1 ml ⋅ min-1 ) as expected (Powell and Skinner 1968; Altura 1971;
Bolme and Gagnon 1972; Nott and Head 1978; Gronert et al. 1980; Wickler and
Horwitz 1984; Kuznetsova et al. 1998; Rohrer et al. 1999). In the ß1/ß2 knockout
mouse this decrease in blood pressure is diminished (Rohrer et al. 1999), whilst βadrenoceptor activation has a positive chronotropic effect which significantly
increases cardiac output (Wickler and Horwitz 1984). Yu and Tyml (1997) reported a
significant concentration-dependent increase in erythrocyte velocity through
upstream arteriole vasodilation during local skeletal muscle capillary application of
isoprenaline, which is diminished during β-adrenoceptor blockade. Belfrage (1978)
reported that skeletal muscle vasculature dilatation is β 2-adrenoceptor-mediated ,
whereas in adipose tissue it is thought to be primarily β 1-adrenoceptor. However,
more recently it was concluded that there are both β 1- and β2-adrenoceptors in
skeletal muscle capillaries that can modulate capillary module blood flow (Yu and
Tyml 1997). It has been suggested that neurogenic β-adrenoceptor (G -proteincoupled) dilatation exists in the vasculature of skeletal muscle and appears to be
limited to the resistance and precapillary arterioles (Lundvall and Jarhult 1974;
Hillman and Lundvall 1981).
No significant effect upon basal oxygen consumption has been reported in
previous studies for isoprenaline (Gronert et al. 1980; van-Hardeveld et al. 1980) or
histamine (Bolme and Gagnon 1972). Bolme and Gagnon (1972) concluded that the
infusion of vasodilating drugs into a constant pressure system does not affect the
size of the capillary bed or change the oxygen consumption in resting or exercising
skeletal muscle once steady-state is reached. However, the initial effect of these
vasodilators significantly increased blood flow and oxygen consumption. Contrary to
this Vetterlein and Schmidt (1974) reported that during infusion of vasodilatory
agents, total blood flow increases in association with reduced perfusion of certain
areas of the musculature. The infusion of vasodilators in a constant flow model
results in increased number of perfused capillaries modules with diminished
erythrocyte velocity (Bolme and Gagnon 1972; Shiota and Sugano 1986; Shiota and
Masumi 1988; Ye et al. 1990; Kuznetsova et al. 1998), however, in a constant
pressure model vasodilation increases total blood flow and the number of capillary
modules perfused (Ye et al. 1995). This increase in total flow has a diminished laser
Doppler signal which is thought to be a result of decreased erythrocyte velocity or
erythrocyte numbers or a combination (Kuznetsova et al. 1998). Vasodilation results
in a significant decrease in the number of perfused capillaries (Vetterlein and
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Schmidt 1975, 1980) and decreases erythrocyte velocity in isolated preparations
(Takakura et al. 1995). These studies show that vasodilation increase s the number of
perfused capillary modules in vivo. This increased surface area would be expected to
increase oxygen uptake by the skeletal muscle, however, this was not the case with
high oxygen content perfusates with reduced erythrocyte velocity through the
capillary. This result may differ in an autoperfused constant flow model where there is
an increase in the number of perfused capillaries with an increase in erythrocyte
transit time, which are conditions found in vivo.
The significant decrease in basal and contraction hindlimb perfusion pressure
after histamine infusion supports previous studies (Haddy 1960; Hashimoto and
Kumakura 1965; Kjellmer and Odelram 1965; Rang et al. 1995). Histamine-mediated
vasodilation is via H 1-receptor activation in humans and a combination of H1- and H2receptors in some experimental animals (dogs and rats) (Rang et al. 1995) and has
been suggested to induce both pre- and post-capillary vessel vasodilation (Kjellmer
and Odelram 1965).
Previous studies support the lack of significant effect upon basal oxygen
consumption by noradrenaline in a variety of models (Grubb and Folk 1977; Gronert
et al. 1980; van-Hardeveld et al. 1980; Shiota and Masumi 1988; Gainer et al. 1993).
Furthermore, neither low nor high dose noradrenaline had any significant effects on
the hindlimb twitch characteristic. If selective vasoconstriction that results in an
increased nutritive flow does occur, it would be expected that there would be
significant change in the muscle twitch characteristics of the stimulated hindlimb due
to greater oxygen availability unless oxygen delivery was already optimal. However,
since there is local metabolite -mediated vasodilation of the nutritive bed, if selective
vasoconstriction of the non -nutritive bed by noradrenaline was to occur then there
may not be any overall significant increase in nutritive blood flow hence no resulting
effect on twitch.

Therefore, when basal metabolism is matched with adequate delivery of
oxygen to skeletal muscle cells (autoperfused hindlimb), the cells remain normoxic.
With an increase in oxygen availability during redistribution of flow no further increase
is possible due to adequately matched oxygen delivery and metabolism. The
changes observed in basal oxygen consumption in other studies would arise from
models where inadequate delivery of oxygen occurs, such as cell-free perfusate. Any
increase in oxygen availability via redistribution would increase oxygen uptake to
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reduce the basal oxygen debt. However, in a constant flow model, vasodilation
results in decreased perfusion pressure and decreased erythrocyte velocity through
the capillary. In a constant pressure model (as found in vivo) vasodilation increases
total flow which would increase the number of perfused capillaries with maintain flow
rate. The study of the effects of blood redistribution during adequate oxygen
availability in autoperfused constant pressure model is required for further
understanding of the relationship between oxygen delivery and uptake.

Increased Oxygen Uptake During Repetitive Contraction.
Isoprenaline

and

histamine

infusion

significantly

increased

oxygen

consumption during repetitive muscle contraction, but not at rest. The ability to further
increase oxygen consumption during muscle contraction could arise from either a)
selective vasodilation of the nutritive pathway; b) non-selective vasodilation to further
increase the number of perfused capillaries; c) unmatched oxygen delivery and
metabolic demand; or d) a direct metabolic effect on the skeletal muscle cells.
Both vasodilators produced dose-dependent decrease s in perfusion pressure
whilst isoprenaline caused an associated dose-dependent increase in oxygen
consumption. Histamine also increased oxygen consumption but this was not doserelated or closely associated with the change in perfusion pressure. Histamine did ,
however, significantly increase the maximal rate of relaxation with a negative dosedependent relationship. Isoprenaline had no corresponding effect upon the twitch
during changes in perfusion pressure and oxygen consumption. The metabolic
effects of the exogenous vasodilator infusion may be brought about by differing
mechanisms. Beta-adrenoceptor activation has a direct positive metabolic effect
upon the skeletal muscle cell whereas histamine may have an indirect effect upon
increased oxygen uptake via increased oxygen availability through vasodilation.
Isoprenaline -mediated vasodilation is associated with an increase in skeletal
muscle oxygen consumption which may not be causal (Wickler and Horwitz 1984; Ye
et al. 1990; Gainer et al. 1993; Ye et al. 1995). Isoprenaline has been shown to be a
potent stimulator of non-shivering thermogenesis as measured by increases in
oxygen consumption (Bolme and Gagnon 1972; Wickler and Horwitz 1984; Gainer et
al. 1993). However, isoprenaline has varying effects on oxygen uptake dependent
upon the duration of the application (Powell and Skinner 1968). Activation of βadrenoceptors results in skeletal muscle glycogenolysis and lipolysis activation which
can impede glucose and free fatty acid uptake during intense exercise (Richter et al.
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1982; Sigal et al. 1994; Rohrer et al. 1999; Sigal et al. 1999). Beta-adrenoceptor
agonists are responsible for increased oxidative metabolism resulting in increased
lactate production, muscle glycogen breakdown , and oxygen consumption with no
effect on ATP or creatine phosphate levels observed in skeletal muscle (Li and
Jefferson 1977). Williams et al. (1984) concluded that β-adrenoceptor density
correlated positively with oxidative capacity in rat skeletal muscle. The significance of
this could be that β-adrenoceptor activity increases oxygen uptake resulting in
increased oxidative metabolism in fast and slow oxidative muscle fibres. These
studies suggest that there is a direct action by activation of β-adrenoceptors on
skeletal muscle metabolism independent of vascular changes.
In a variety of studies β-adrenoceptor activity has been linked to skeletal
muscle tremor. The increased muscle activity during skeletal muscle tremor would
result in an increase in oxygen uptake due to increased metabolic demand. This
tremor can be increased by infusion of isoprenaline and adrenaline, and blocked by
propranolol, but not by atenolol (β 1-antagonists). Therefore, the β2-adrenoceptor
mediates skeletal muscle tremor (Marlin and Turner 1975; Abila et al. 1985). It has
been shown more recently that β2-adrenoceptors are the predominant subtype found
on the sarcolemma of mammalian skeletal muscle (Cairns and Dulhunty 1993).
Hallberg and Almgren (1985) reported that β-adrenoceptor stimulation with
hydrophilic agonists neither induced nor potentiated established centrally evoked
mild tremor in conscious unrestrained rats. This is contrary to results found in human
skeletal muscle, where increased metabolic rate during catecholamine release
occurs via β 1-adrenoceptor activation (Lamont et al. 1997). It was concluded that β 2adrenoceptors do not mediate the same functions in rat skeletal muscle as in
humans. These studies suggest that the role of the sub-types of β-adrenoceptors
varies within different species. Furthermore, increased muscle fibre recruitment via βadrenoceptor-mediated muscle tremor may play a role in the increased oxygen
consumption observed during the contraction protocol in this study.
There is no significant change in resting heart rate or mean blood pressure in
the β 1/β 2 knockout mouse, however the effect of isoprenaline on blood pressure and
heart rate is significantly diminished during basal conditions (Rohrer et al. 1999).
Isoprenaline has no significant effect on resting oxygen consumption but does
increase lactate output (Gronert et al. 1980; van_Hardeveld et al. 1980). The β 1/β 2
knockout mouse has a significantly lower oxygen consumption, carbon dioxide
production, and heart rate during 30 minutes of treadmill running. It can be concluded
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that rodent β-adrenoceptors influence skeletal muscle metabolic activity during
exercise. It was suggested that the decrease or attenuated increase of oxygen
consumption could arise through ß-agonist hyperpolarisation of the muscle
membrane resulting in the decrease in oxygen demand (Gronert et al. 1980). These
studies suggest that there is a heightened effect of β-adrenoceptor activity during
exercise . This may explain the increase in oxygen consumption after isoprenaline
infusion during the contraction protocol.
Isoprenaline had no significant effect on muscle twitch in the autoperfused
hindlimb. Beta-adrenoceptor agonists have been reported to reduce the tension and
fusion of incomplete tetanic contraction in slow-twitch skeletal muscle such as cat
soleus (Bowman and Nott 1978). This has been contested more recently by Cairns
and Dulhunty (1993) who reported that β-adrenoceptor agonists increase force
production through increased cyclic AMP activity in rat soleus muscle. Betaadrenoceptor activation alters the rate of relaxation of both twitch and tetanic
contractions however this is dependent upon fibre type. In the isolated cat and
guinea pig soleus muscle, isoprenaline significantly depresses the tension as well as
the degree of fusion of incomplete tetanic contractions (Nott and Head 1978).
However in a more recent study, β 2-adrenoceptor activation resulted in an increase in
peak twitch and peak tetanic force in innervated or denervated isolated rat soleus
muscle (Cairns and Dulhunty 1993). Twitch force is increased by activation of βadrenoceptors, and since cyclic AMP application mimicked the effects of βadrenoceptors, the activation of β-adrenoceptors is mediated by increases in the
myoplasmic cyclic AMP concentration. This suggests that the increase in force
development is mediated by cyclic AMP levels and therefore the increase in oxygen
consumption may not result in increased cAMP levels.
Overall, this study and others suggest that the effects of isoprenaline on
hindlimb oxygen consumption are most likely to be due to direct activation of skeletal
muscle β-adrenoceptors which lead to increases in metabolic activity during muscle
contraction rather than selective vasodilation. The increase in oxygen consumption
during contraction is the result of increased sensitivity of the β-adrenoceptor leading
to increased oxidative metabolism.

In the past, it has been suggested that histamine produces exercise -induced
vasodilation in both skeletal and cardiac muscle and reactive hyperaemia (Berne
1964) although this has not been supported by subsequent experiments. However,
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histamine and/or prostaglandin release has been suggested to play a role in postexercise prolonged vasodilation (Morganroth et al. 1977). Unlike isoprenaline, there
was no clear relationship between increased oxygen consumption and reduced
perfusion pressure after histamine infusion during the muscle contraction.
Histamine infusion significantly increased oxygen consumption but only
during muscle contraction. Even though there was no significant effect on the rate of
force development, there was a significant increase in the rate of relaxation which
could be due to an increase in nutritive flow through increased substrate availability,
as relaxation is a highly energy dependent component of muscle contraction which is
reliant on active removal of calcium from the contractile apparatus. Bolme and
Gagnon (1972) reported that histamine initially increases oxygen consumption .
However once steady state is restored one to five minutes post-infusion, there is no
significant effect. Using the contracting perfused cat hindlimb Sonnenchein and
Hirvonen (1961) assumed that maximal muscle force is an index of nutritive blood
flow. Histamine decreased force production by either an increase in non-nutritive flow
or a decrease in nutritive flow. However, Kjellmer and Odelram (1965) observed that
histamine increased nutritive blood flow at rest in the perfused cat hindlimb due to
increases in capillary filtration coefficient. Neither of these two studies measured
oxygen consumption, so any changes in force production or capillary coefficient may
not be causative through redirection of blood flow into or away from either vascular
route. In this study, the relationship between perfusion pressure and the maximal rate
of relaxation gives rise to the possibility that the increase in the number of perfused
capillary modules increase metabolite efflux, resulting in a greater rate of relaxation.
Selective vasodilation by histamine in this thesis cannot be concluded or
dismissed. The increase in hindlimb oxygen consumption during muscle contraction
and the increased rate of relaxation could arise through selective vasodilation of the
nutritive route or through non-selective vasodilation of the transverse arteriole, which
would increase perfusion of more capillaries hence increasing oxygen consumption
and nutrient delivery as well as metabolite efflux. The direct effect of histamine on
skeletal muscle cells has not been reported, but cannot be ruled out as an
explanation of these phenomena.

The effects of isoprenaline and histamine infusion during muscle contraction
on skeletal muscle metabolism are via different mechanisms. Isoprenaline has a
direct effect upon the skeletal muscle cell by stimulating β-adrenoceptors resulting in
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increased oxidative metabolism, whilst histamine has no direct effect. It is doubtful
that histamine does not selectively increase nutritive blood flow, as there was no
strong correlation between changes in perfusion pressure and oxygen consumption.

4.2

FUTURE DIRECTIONS

4.2.1 Application of the Findings
The results of these studies show that skeletal muscle metabolism can be
influenced by redistribution of blood flow. This result could be explained by the
existence of parallel vascular pathways within the skeletal muscle. Selective
vasoconstriction by noradrenaline (Type A) to increase perfusion of muscle fibre
associated capillaries does not increase oxygen consumption during adequate
oxygen delivery. Increased availability of oxygen when basal metabolic rate is
matched does not increase oxygen consumption. On the other hand, serotonin (Type
B) decreased oxygen consumption which could be a result of selective
vasoconstriction of the nutritive bed to increase perfusion of the connective tissue
and adipose (Figure 4.2). Physiological control of skeletal muscle blood flow in vivo
occurs via vasodilation. However, we were unable to identify a vasodilator that could
selectively vasodilate the non-nutritive pathway resulting in a decrease in hindlimb
oxygen consumption in a similar fashion to serotonin. Eight vasodilators with a variety
of mechanisms such as nitric oxide donors, inflammatory mediators, G-protein
coupled receptors, calcium channel blockers, and M3-glandular receptors that release
nitric oxide were screened. The inability to selectively vasodilate different parts of the
microcirculation does not negate the existence of a dual circulation . However, it
appears that the location from which the vasodilatory agents are released maybe the
crucial factor to such selective vasodilation .

Increased capillary module perfusion via increase nutritive flow to increase
oxygen availability above adequate supply does not increase resting oxygen
consumption . Resting muscle can contribute to whole body thermogenesis, which is
thought to be regulated by the vascular system and delivery of nutrients (Clark et al.
1994), however increasing supply above demand does not increase uptake.
Therefore the contribution to whole body thermogenesis by skeletal muscle is
regulated by a combination of central and peripheral mechanisms, such as neural
and circulating hormones to stimulate metabolism resulting in thermogenesis.
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Skeletal muscle metabolism is tightly regulated with blood flow. However, increase d
oxygen availability resulting from vasoconstriction, does not increase metabolic rate
when there is no change in metabolic demand. Even so , when oxygen availability is
reduced via selective vasoconstriction, metabolism is diminished.
The existence of a dual vascular arrangement in skeleta l muscle is a distinct
possibility. The clearance rate studies, pharmacological studies and direct
observation studies all support the notion of a dual circulation , although definitive
evidence in weight bearing muscles (unlike the tenuissimus, cremaster muscles) is
required. The redistribution of blood flow by serotonin resulting in reduced oxygen
consumption could play a part in nutrient retention when released from platelets
during times of aggregation such as haemorrhage. During the early phase posthaemorrhage (30% haemorrhage), Borgström et al. (1990) observed that the
reduction in total blood flow was diverted into the non -nutritive at the expense of
nutritive flow to the muscle tissue.
Speculating on the significance of his and his colleague’s work, Clark stated
that reduced physical activity and stress each contribute to poor nutritive flow in
muscle, which leads to diminished ability to deliver nutrients, such as glucose and
amino acids, and hormones, such as insulin, to the muscle fibres. This speculation
leads to the conclusion that reduced physical activity may cause insulin resistance
and reduced protein synthesis.
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4.2.2 Further Investigations
The development of the autoperfused hindlimb as a physiological model used
in pharmacological studies has possibilities for improvement. Application of
pharmacological agents without the injection artefact, and slow infusion to increase
the duration of the stimulus is one possibility. Add to this real time continuous
recording of oxygen consumption and the ability to determine if the change in oxygen
consumption during agonist infusion is associated with perfusion changes or the
direct effects of the agonist on the muscle cells will be improved.
The study of a vasodilator that is released exclusively from adipose tissue
could result in an increase in non-nutritive flow. This vasodilator could have receptors
located exclusively in an area of the vasculature resulting in selective vasodilation to
reduce oxygen consumption.
Increasing the duration of the contraction stimulation to greater than three
minutes and with greater duration of agonist application will enhance the ability to
observe any changes in twitch characteristics associated with prolonged
redistribution of blood flow and hence nutrient delivery.
The use of radio -labelled vasoactive agents such as serotonin and
noradrenaline or their antagonists could be used to localise their sites of action with a
beta-imager. This could be used to determine whether the re is a distribution
difference between the respective receptors which gives rise to the differences
observed in hindlimb oxygen consumption and metabolism.
A more in-depth study that includes antagonists in the autoperfused hindlimb
could help to determine whether the changes in oxygen consumption and perfusion
pressure induced by agonist infusion can be blocked. This was attempted , however,
the combination of doses of agonist and antagonist as well as time to reach maximal
saturation of receptors by the antagonist prior to agonist infusion made it difficult to
achieve in time allocated to perform this study. The most effective application of the
antagonist was also a source of difficulty. The choice of whether to infuse intraarterially into the hind limb, or intra -venously for maximal mixing within the blood or
intra-peritoneal/intra-muscularly added to possible combinations which could not be
determined within the time frame of this study.
The effect of diabetes and obesity on vasoactive agents could be studied to
determine whether changes in the vasculature of the skeletal muscle are detrimental
to nutrient delivery, metabolic rate and performance during exercise (twitch
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characteristics). In these two populations or a normal population, the effects of
exercise training (such as running or swimming) could be studied to determine
whether there is a beneficial relationship between nutrient delivery and lifestyle. The
effect of high fat or high n-3 fatty acid diet on nutrient delivery could furthe r this study
with the hypothesis that a sedentary lifestyle leads to an increased non-nutritive flow.
It has been shown that a diet high in n-3 fatty acids ha s a positive effect upon cellular
metabolic rate and have antiarrhythmic effects whilst lipid infusion prevents insulinmediated capillary recruitment and muscle glucose uptake in skeletal muscle
(McLennan et al. 1990; Charnock et al. 1992; Pepe and McLennan 1996; McLennan
2001; Clerk et al. 2002; Janiak et al. 2002). This increase in non-nutritive flow could
result in a diminished ability of skeletal muscle to take up glucose and possibly
results in vascular rearrangements within the musculature (Rattigan et al. 1997b;
Sigal et al. 1999; Rattigan et al. 2001; Vincent et al. 2002). It has recently been
shown that vascular remodelling occurs in syndrome X animal models, which may
result in reduced perfusion capacity and peripheral microvascular disease (Stepp et
al. 2004). Further studies might also focus on whether a diet high in n-3 fatty acids
result in changes in blood flow or whether exercise in a diabetic or insulin resistant
animal overcome the detrimental effects of a sedentary lifestyle on nutrient and
hormone delivery and hence metabolism through changes in vascular structure .
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4.3

FINAL CONCLUSIONS

The capability to retain vascular tone in the autoperfused hindlimb is of great
importance when studying skeletal muscle metabolism, particularly during
contraction, as metabolically driven increases in blood flow arise from upstream
vasodilation. The retention of vascular tone also results in the ability to maintain
blood flow within the range observed in vivo. Furthermore the use of erythrocytes
results in high oxygen content, which is important for high oxygen availability to
sustain muscle contraction and basal metabolism with in vivo blood flow rates.
Therefore , these physiologically relevant conditions are important for the study of in
vivo skeletal muscle metabolism during pharma cological or physiological stimuli.

The effects of vasoconstrictors were largely overcome by increased muscle
metabolic activity. This taken together with the inability to identify vasodilators with
differential effects on oxygen consumption suggests that blood flow redistribution via
vasodilation is determined by the locale of vasodilator release rather than receptor
distribution. The exogenous regulation of dual circulation appears most relevant
during resting conditions. Whilst during exercise it is under local control via
vasoactive metabolites.

The existence of dual circulation with in skeletal muscle is a distinct possibility.
The ability of serotonin to decrease basal and exercising skeletal muscle oxygen
consumption during changes in perfusion pressure gives rise support to this notion. A
non-nutritive pathway may act as a low metabolic route during times where nutrient
retention is of great importance (such as a large haemorrhage). Many studies have
suggested that the non-nutritive route is the dominant route at rest. Therefore, blood
flow may be the redistributed from the non-nutritive route into the nutritive route
during the early phases of increased metabolic demand , such as exercise. This
would result in an increase in oxygen availability to reduce, but not negate, the
severity of skeletal muscle oxygen debt, which is observed during the transition from
rest to exercise.
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In the autoperfused hindlimb at rest, selective increases in oxygen
consumption by vasoconstrictors or vasodilators were not demonstrable. On the
other hand, reduced oxygen consumption was demonstrated with serotonin or high
noradrenaline dose. The ability to greatly increase hindlimb oxygen consumption by
increasing metabolic demand through muscle contraction but not through increasing
muscle blood flow suggests that in vitro, muscle oxygen delivery is adequate and
redistribution of perfusate to increase oxygen consumption is largely a phenomenon
of the high flow, low oxygen delivery preparations. Considering the ability of muscle
metabolism to override the exogenously produced flow distribution, a role for
noradrenaline in vivo might be in the expectant rise in sympathetic nervous activity
that precedes exercise to provide an initial redistribution prior to the onset of muscle
activity. While not producing any increase in oxygen consumption, it would provide
increased delivery in preparation for (anticipation of) the impending muscle activity.
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Appendix 1 : The autoperfused hindlimb model during a basal experiment,
wide shot.
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Appendix 2 : The autoperfused hindlimb model during a basal experiment,
close shot.
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Appendix 3: Oxygen Consumption Calculation Excel Spreadsheet and Formulae.
M
A
1 File Name
2
3
4
5
6
7
8 Mean
9 Std
10 SEM

N

O

P

Q

B

C

D

E

F

Group Name

Drug Number

Sample

Dose

Body_weight(g)

AVERAGE(F2:F7)
STDEV(F2:F7)
F9/6

G
H
I
J
K
L
1 Total_LHL(wet) Room temperature (C) Room temperature (K) Atmospheric pressure (mmHg) Atmospheric pressure (atm) UGC (L atm / mol / K)
2
23
296
760J2*(1/760)
0.0821
3
4
5
6
7
8
9
10
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1 Flow_rate(ml / min) Peak_hindlimb_pressure(mmHg) Hindlimb_pressure(mmHg) Arterial K+
2
1
3
4
5
6
7

Arterial_pH

8
9
10

R
S
1 Arterial_pO 2 (mmHg) Arterial_pCO2 (mmHg)
2
3
4
5
6
7

T

U

V

Arterial_Hct (%)

Arterial_estimated Hb (g/dL)

Arterial_HCO3 - (mmol/L)

8
9
10
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W
1 Arterial_TCO2 (mmol/L)
2
3
4
5
6
7

X

Y

Arterial_BEecf (mmol/L)

Arterial_SO2 c (%)

AA

AB

Arterial O2 conc.(ml/100ml WB)

Arterial O2 conc.(mol/100ml WB)

(1.39*U2*Y2)+(0.003*R2)

(K2*(AA2/1000))/(L2*I2)

8
9
10

Z
1 pK
2 6.086+(0.042*(7.4-Q3))+((38-H3)*(0.00472+(0.00139*(7.4-Q3))))
3
4
5
6
7
8
9
10
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1 Arterial O 2 conc.(umol/ml)
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Drug Venous K+

Drug Venous_pH

Drug Venous_pO 2 (mmHg)
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AI
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Drug Venous_estimated Hb (g/dL)

Drug Venous_HCO3 - (mmol/L) Drug Venous_TCO2 (mmol/L) Drug Venous_BEecf (mmol/L)
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9
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1 Drug Venous_Hct (%)
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3
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9
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AM
1 Drug Venous_SO 2c (%)
2
3
4
5
6
7

AN

AO

Drug pK

solubility constant

6.086+(0.042*(7.4-AE3))+((38-H3)*(0.00472+(0.00139*(7.4-AE3))))

0.0307+ (0.00057*(37-H3))+(0.00002*(37-H3)*(37 -H3))
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1 Drug (A-V) O2 difference (ml/100ml)
2 AA2-AP2
3
4
5
6
7

AT

AU

AV

Drug (A-V) O 2 difference (umol/ml)

Drug O 2 consumption (ml/100ml/min)

Drug O 2 consumption (ml/100ml/min/g)
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AS2*M2

AU2/G2
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AY

AZ

Drug O 2 consumption (umol/min/g)
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Basal Venous_pH

8
9
10
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1 Drug O 2 consumption (umol/min)
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3
4
5
6
7

AW2/G2

8
9
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BA
1Basal Venous_pO 2 (mmHg)
2
3
4
5
6
7

BB

BC

BD

Basal Venous_pCO2 (mmHg)

Basal Venous_Hct (%)

Basal Venous_estimated Hb (g/dL)

BG

BH

Basal Venous_BEecf (mmol/L)

Basal Venous_SO 2c (%)

8
9
10
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BF
1Basal Venous_HCO3- (mmol/L) Basal Venous_TCO2 (mmol/L)
2
3
4
5
6
7
8
9
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1
2
3
4
5
6
7

BI

BJ

Basal pK

solubility constant

6.086+(0.042*(7.4-AY3))+((38-P3)*(0.00472+(0.00139*(7.4-AY3))))

0.0307+ (0.00057*(37-P3))+(0.00002*(37-P3)*(37-P3))

BK

BL

Basal Venous O 2 conc.(ml/100ml WB)

Basal Venous O 2 conc.(mol/100ml WB)

(1.39*BC3*BH)+(0.003*AZ3)

(S3*(BK3/1000))/(T3*Q3)

8
9
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1
2
3
4
5
6
7
8
9
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1
2
3
4
5
6
7

BM

BN

BO

BP

Basal Venous O2 conc.(umol/ml)

Basal (A -V) O2 difference (ml/100ml)

Basal (A-V) O 2 difference (umol/ml)

Basal O2 consumption (ml/100ml/min)

(BL3*1000000)/100

AD3-BK3

AF3-BM3

BN3*U3

BQ

BR

BS

BT

Basal O 2 consumption (ml/100ml/min/g)

Basal O2 consumption (umol/min)

Basal O2 consumption (umol/min/g)

Change O2 consumption (umol/min/g)

BP3/O3

U3*BO3

BR3/O3

AX3-BS3

8
9
10

1
2
3
4
5
6
7
8
9
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